Loading...

Douglas Galasko

Title(s)Professor In Residence, Neurosciences
SchoolHealth Sciences
Address9500 Gilman Drive #0948
La Jolla CA 92093
Phone858-246-1240
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    Translational Center for Alzheimer's Disease Target and Drug Discovery
    NIH/NIA R34AG049646Sep 30, 2014 - Aug 31, 2015
    Role: Principal Investigator
    Biomarkers in Aging, MCI and Alzheimer's Disease
    NIH/NIA R01AG023185Sep 30, 2003 - Jul 31, 2009
    Role: Principal Investigator
    Novel Mechanisms of NSAID Action in Alzheimer's Disease
    NIH/NIA P01AG020206Apr 1, 2002 - Jun 30, 2014
    Role: Co-Investigator
    Alzheimer's Disease Cooperative Study
    NIH/NIA U19AG010483Jul 1, 1997 - Nov 30, 2017
    Role: Co-Investigator
    Alzheimer's Disease Cooperative Study (ADCS)
    NIH/NIA U01AG010483Jul 1, 1997 - Sep 14, 2001
    Role: Co-Investigator
    UCSD Alzheimer's Disease Research Center P50
    NIH/NIA P50AG005131Apr 1, 1997 - Mar 31, 2019
    Role: Principal Investigator
    Age related neurodegenerative diseases in Micronesia
    NIH/NIA P01AG014382Mar 1, 1997 - May 31, 2002
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. A decade of Alzheimer's Research & Therapy: reflections on the past, present, and future. Alzheimers Res Ther. 2020 May 30; 12(1):67. Galasko D, Scheltens P. PMID: 32473646.
      View in: PubMed   Mentions:    Fields:    
    2. Cognitive decline profiles differ in Parkinson disease dementia and dementia with Lewy bodies. Neurology. 2020 Apr 24. Smirnov DS, Galasko D, Edland SD, Filoteo JV, Hansen LA, Salmon DP. PMID: 32332125.
      View in: PubMed   Mentions:    Fields:    
    3. Research criteria for the diagnosis of prodromal dementia with Lewy bodies. Neurology. 2020 Apr 28; 94(17):743-755. McKeith IG, Ferman TJ, Thomas AJ, Blanc F, Boeve BF, Fujishiro H, Kantarci K, Muscio C, O'Brien JT, Postuma RB, Aarsland D, Ballard C, Bonanni L, Donaghy P, Emre M, Galvin JE, Galasko D, Goldman JG, Gomperts SN, Honig LS, Ikeda M, Leverenz JB, Lewis SJG, Marder KS, Masellis M, Salmon DP, Taylor JP, Tsuang DW, Walker Z, Tiraboschi P. PMID: 32241955.
      View in: PubMed   Mentions:    Fields:    
    4. Clinical and Dopamine Transporter Imaging Characteristics of Leucine- Rich Repeat Kinase 2 (LRRK2) and Glucosylceramidase Beta (GBA) Parkinson's Disease Participants in the Parkinson's Progression Markers Initiative: A Cross-Sectional Study. Mov Disord. 2020 Feb 19. Simuni T, Brumm MC, Uribe L, Caspell-Garcia C, Coffey CS, Siderowf A, Alcalay RN, Trojanowski JQ, Shaw LM, Seibyl J, Singleton A, Toga AW, Galasko D, Foroud T, Nudelman K, Tosun-Turgut D, Poston K, Weintraub D, Mollenhauer B, Tanner CM, Kieburtz K, Chahine LM, Reimer A, Hutten S, Bressman S, Marek K. PMID: 32073681.
      View in: PubMed   Mentions:    Fields:    
    5. Analysis of neurodegenerative disease-causing genes in dementia with Lewy bodies. Acta Neuropathol Commun. 2020 01 29; 8(1):5. Orme T, Hernandez D, Ross OA, Kun-Rodrigues C, Darwent L, Shepherd CE, Parkkinen L, Ansorge O, Clark L, Honig LS, Marder K, Lemstra A, Rogaeva E, St George-Hyslop P, Londos E, Zetterberg H, Morgan K, Troakes C, Al-Sarraj S, Lashley T, Holton J, Compta Y, Van Deerlin V, Trojanowski JQ, Serrano GE, Beach TG, Lesage S, Galasko D, Masliah E, Santana I, Pastor P, Tienari PJ, Myllykangas L, Oinas M, Revesz T, Lees A, Boeve BF, Petersen RC, Ferman TJ, Escott-Price V, Graff-Radford N, Cairns NJ, Morris JC, Pickering-Brown S, Mann D, Halliday G, Stone DJ, Dickson DW, Hardy J, Singleton A, Guerreiro R, Bras J. PMID: 31996268.
      View in: PubMed   Mentions:    Fields:    
    6. Clonally expanded CD8 T cells patrol the cerebrospinal fluid in Alzheimer's disease. Nature. 2020 01; 577(7790):399-404. Gate D, Saligrama N, Leventhal O, Yang AC, Unger MS, Middeldorp J, Chen K, Lehallier B, Channappa D, De Los Santos MB, McBride A, Pluvinage J, Elahi F, Tam GK, Kim Y, Greicius M, Wagner AD, Aigner L, Galasko DR, Davis MM, Wyss-Coray T. PMID: 31915375.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    7. Anterior Cingulate Structure and Perfusion is Associated with Cerebrospinal Fluid Tau among Cognitively Normal Older Adult APOE?4 Carriers. J Alzheimers Dis. 2020; 73(1):87-101. Hays CC, Zlatar ZZ, Meloy MJ, Osuna J, Liu TT, Galasko DR, Wierenga CE. PMID: 31743999.
      View in: PubMed   Mentions: 1     Fields:    
    8. Correction to: 4-Repeat tau seeds and templating subtypes as brain and CSF biomarkers of frontotemporal lobar degeneration. Acta Neuropathol. 2020 Jan; 139(1):79-81. Saijo E, Metrick MA, Koga S, Parchi P, Litvan I, Spina S, Boxer A, Rojas JC, Galasko D, Kraus A, Rossi M, Newell K, Zanusso G, Grinberg LT, Seeley WW, Ghetti B, Dickson DW, Caughey B. PMID: 31748840.
      View in: PubMed   Mentions:    Fields:    
    9. Associations Between Microstructure, Amyloid, and Cognition in Amnestic Mild Cognitive Impairment and Dementia. J Alzheimers Dis. 2020; 73(1):347-357. Reas ET, Hagler DJ, Kuperman JM, Wierenga CE, Galasko D, White NS, Dale AM, Banks SJ, McEvoy LK, Brewer JB. PMID: 31796676.
      View in: PubMed   Mentions:    Fields:    
    10. Synaptic biomarkers in CSF aid in diagnosis, correlate with cognition and predict progression in MCI and Alzheimer's disease. Alzheimers Dement (N Y). 2019; 5:871-882. Galasko D, Xiao M, Xu D, Smirnov D, Salmon DP, Dewit N, Vanbrabant J, Jacobs D, Vanderstichele H, Vanmechelen E, Worley P. PMID: 31853477.
      View in: PubMed   Mentions:
    11. miR-212 and miR-132 Are Downregulated in Neurally Derived Plasma Exosomes of Alzheimer's Patients. Front Neurosci. 2019; 13:1208. Cha DJ, Mengel D, Mustapic M, Liu W, Selkoe DJ, Kapogiannis D, Galasko D, Rissman RA, Bennett DA, Walsh DM. PMID: 31849573.
      View in: PubMed   Mentions:
    12. Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study. Lancet Neurol. 2020 Jan; 19(1):71-80. Simuni T, Uribe L, Cho HR, Caspell-Garcia C, Coffey CS, Siderowf A, Trojanowski JQ, Shaw LM, Seibyl J, Singleton A, Toga AW, Galasko D, Foroud T, Tosun D, Poston K, Weintraub D, Mollenhauer B, Tanner CM, Kieburtz K, Chahine LM, Reimer A, Hutten SJ, Bressman S, Marek K. PMID: 31678032.
      View in: PubMed   Mentions: 1     Fields:    
    13. 4-Repeat tau seeds and templating subtypes as brain and CSF biomarkers of frontotemporal lobar degeneration. Acta Neuropathol. 2020 01; 139(1):63-77. Saijo E, Metrick MA, Koga S, Parchi P, Litvan I, Spina S, Boxer A, Rojas JC, Galasko D, Kraus A, Rossi M, Newell K, Zanusso G, Grinberg LT, Seeley WW, Ghetti B, Dickson DW, Caughey B. PMID: 31616982.
      View in: PubMed   Mentions:    Fields:    
    14. MCI-to-normal reversion using neuropsychological criteria in the Alzheimer's Disease Neuroimaging Initiative. Alzheimers Dement. 2019 10; 15(10):1322-1332. Thomas KR, Edmonds EC, Eppig JS, Wong CG, Weigand AJ, Bangen KJ, Jak AJ, Delano-Wood L, Galasko DR, Salmon DP, Edland SD, Bondi MW. PMID: 31495605.
      View in: PubMed   Mentions:    Fields:    
    15. Author Correction: Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aß, tau, immunity and lipid processing. Nat Genet. 2019 Sep; 51(9):1423-1424. Kunkle BW, Grenier-Boley B, Sims R, Bis JC, Damotte V, Naj AC, Boland A, Vronskaya M, van der Lee SJ, Amlie-Wolf A, Bellenguez C, Frizatti A, Chouraki V, Martin ER, Sleegers K, Badarinarayan N, Jakobsdottir J, Hamilton-Nelson KL, Moreno-Grau S, Olaso R, Raybould R, Chen Y, Kuzma AB, Hiltunen M, Morgan T, Ahmad S, Vardarajan BN, Epelbaum J, Hoffmann P, Boada M, Beecham GW, Garnier JG, Harold D, Fitzpatrick AL, Valladares O, Moutet ML, Gerrish A, Smith AV, Qu L, Bacq D, Denning N, Jian X, Zhao Y, Del Zompo M, Fox NC, Choi SH, Mateo I, Hughes JT, Adams HH, Malamon J, Sanchez-Garcia F, Patel Y, Brody JA, Dombroski BA, Naranjo MCD, Daniilidou M, Eiriksdottir G, Mukherjee S, Wallon D, Uphill J, Aspelund T, Cantwell LB, Garzia F, Galimberti D, Hofer E, Butkiewicz M, Fin B, Scarpini E, Sarnowski C, Bush WS, Meslage S, Kornhuber J, White CC, Song Y, Barber RC, Engelborghs S, Sordon S, Voijnovic D, Adams PM, Vandenberghe R, Mayhaus M, Cupples LA, Albert MS, De Deyn PP, Gu W, Himali JJ, Beekly D, Squassina A, Hartmann AM, Orellana A, Blacker D, Rodriguez-Rodriguez E, Lovestone S, Garcia ME, Doody RS, Munoz-Fernadez C, Sussams R, Lin H, Fairchild TJ, Benito YA, Holmes C, Karamujic-Comic H, Frosch MP, Thonberg H, Maier W, Roshchupkin G, Ghetti B, Giedraitis V, Kawalia A, Li S, Huebinger RM, Kilander L, Moebus S, Hernández I, Kamboh MI, Brundin R, Turton J, Yang Q, Katz MJ, Concari L, Lord J, Beiser AS, Keene CD, Helisalmi S, Kloszewska I, Kukull WA, Koivisto AM, Lynch A, Tarraga L, Larson EB, Haapasalo A, Lawlor B, Mosley TH, Lipton RB, Solfrizzi V, Gill M, Longstreth WT, Montine TJ, Frisardi V, Diez-Fairen M, Rivadeneira F, Petersen RC, Deramecourt V, Alvarez I, Salani F, Ciaramella A, Boerwinkle E, Reiman EM, Fievet N, Rotter JI, Reisch JS, Hanon O, Cupidi C, Uitterlinden AGA, Royall DR, Dufouil C, Maletta RG, de Rojas I, Sano M, Brice A, Cecchetti R, George-Hyslop PS, Ritchie K, Tsolaki M, Tsuang DW, Dubois B, Craig D, Wu CK, Soininen H, Avramidou D, Albin RL, Fratiglioni L, Germanou A, Apostolova LG, Keller L, Koutroumani M, Arnold SE, Panza F, Gkatzima O, Asthana S, Hannequin D, Whitehead P, Atwood CS, Caffarra P, Hampel H, Quintela I, Carracedo Á, Lannfelt L, Rubinsztein DC, Barnes LL, Pasquier F, Frölich L, Barral S, McGuinness B, Beach TG, Johnston JA, Becker JT, Passmore P, Bigio EH, Schott JM, Bird TD, Warren JD, Boeve BF, Lupton MK, Bowen JD, Proitsi P, Boxer A, Powell JF, Burke JR, Kauwe JSK, Burns JM, Mancuso M, Buxbaum JD, Bonuccelli U, Cairns NJ, McQuillin A, Cao C, Livingston G, Carlson CS, Bass NJ, Carlsson CM, Hardy J, Carney RM, Bras J, Carrasquillo MM, Guerreiro R, Allen M, Chui HC, Fisher E, Masullo C, Crocco EA, DeCarli C, Bisceglio G, Dick M, Ma L, Duara R, Graff-Radford NR, Evans DA, Hodges A, Faber KM, Scherer M, Fallon KB, Riemenschneider M, Fardo DW, Heun R, Farlow MR, Kölsch H, Ferris S, Leber M, Foroud TM, Heuser I, Galasko DR, Giegling I, Gearing M, Hüll M, Geschwind DH, Gilbert JR, Morris J, Green RC, Mayo K, Growdon JH, Feulner T, Hamilton RL, Harrell LE, Drichel D, Honig LS, Cushion TD, Huentelman MJ, Hollingworth P, Hulette CM, Hyman BT, Marshall R, Jarvik GP, Meggy A, Abner E, Menzies GE, Jin LW, Leonenko G, Real LM, Jun GR, Baldwin CT, Grozeva D, Karydas A, Russo G, Kaye JA, Kim R, Jessen F, Kowall NW, Vellas B, Kramer JH, Vardy E, LaFerla FM, Jöckel KH, Lah JJ, Dichgans M, Leverenz JB, Mann D, Levey AI, Pickering-Brown S, Lieberman AP, Klopp N, Lunetta KL, Wichmann HE, Lyketsos CG, Morgan K, Marson DC, Brown K, Martiniuk F, Medway C, Mash DC, Nöthen MM, Masliah E, Hooper NM, McCormick WC, Daniele A, McCurry SM, Bayer A, McDavid AN, Gallacher J, McKee AC, van den Bussche H, Mesulam M, Brayne C, Miller BL, Riedel-Heller S, Miller CA, Miller JW, Al-Chalabi A, Morris JC, Shaw CE, Myers AJ, Wiltfang J, O'Bryant S, Olichney JM, Alvarez V, Parisi JE, Singleton AB, Paulson HL, Collinge J, Perry WR, Mead S, Peskind E, Cribbs DH, Rossor M, Pierce A, Ryan NS, Poon WW, Nacmias B, Potter H, Sorbi S, et al. PMID: 31417202.
      View in: PubMed   Mentions:    Fields:    
    16. Longitudinal analyses of cerebrospinal fluid a-Synuclein in prodromal and early Parkinson's disease. Mov Disord. 2019 09; 34(9):1354-1364. Mollenhauer B, Caspell-Garcia CJ, Coffey CS, Taylor P, Singleton A, Shaw LM, Trojanowski JQ, Frasier M, Simuni T, Iranzo A, Oertel W, Siderowf A, Weintraub D, Seibyl J, Toga AW, Tanner CM, Kieburtz K, Chahine LM, Marek K, Galasko D. PMID: 31361367.
      View in: PubMed   Mentions: 1     Fields:    
    17. Distinct structural correlates of the dominant and nondominant languages in bilinguals with Alzheimer's disease (AD). Neuropsychologia. 2019 09; 132:107131. Smirnov DS, Stasenko A, Salmon DP, Galasko D, Brewer JB, Gollan TH. PMID: 31271821.
      View in: PubMed   Mentions:    Fields:    
    18. Heritability and genetic variance of dementia with Lewy bodies. Neurobiol Dis. 2019 07; 127:492-501. Guerreiro R, Escott-Price V, Hernandez DG, Kun-Rodrigues C, Ross OA, Orme T, Neto JL, Carmona S, Dehghani N, Eicher JD, Shepherd C, Parkkinen L, Darwent L, Heckman MG, Scholz SW, Troncoso JC, Pletnikova O, Dawson T, Rosenthal L, Ansorge O, Clarimon J, Lleo A, Morenas-Rodriguez E, Clark L, Honig LS, Marder K, Lemstra A, Rogaeva E, St George-Hyslop P, Londos E, Zetterberg H, Barber I, Braae A, Brown K, Morgan K, Troakes C, Al-Sarraj S, Lashley T, Holton J, Compta Y, Van Deerlin V, Serrano GE, Beach TG, Lesage S, Galasko D, Masliah E, Santana I, Pastor P, Diez-Fairen M, Aguilar M, Tienari PJ, Myllykangas L, Oinas M, Revesz T, Lees A, Boeve BF, Petersen RC, Ferman TJ, Graff-Radford N, Cairns NJ, Morris JC, Pickering-Brown S, Mann D, Halliday GM, Hardy J, Trojanowski JQ, Dickson DW, Singleton A, Stone DJ, Bras J. PMID: 30953760.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    19. Tau PET in autosomal dominant Alzheimer's disease: relationship with cognition, dementia and other biomarkers. Brain. 2019 04 01; 142(4):1063-1076. Gordon BA, Blazey TM, Christensen J, Dincer A, Flores S, Keefe S, Chen C, Su Y, McDade EM, Wang G, Li Y, Hassenstab J, Aschenbrenner A, Hornbeck R, Jack CR, Ances BM, Berman SB, Brosch JR, Galasko D, Gauthier S, Lah JJ, Masellis M, van Dyck CH, Mintun MA, Klein G, Ristic S, Cairns NJ, Marcus DS, Xiong C, Holtzman DM, Raichle ME, Morris JC, Bateman RJ, Benzinger TLS. PMID: 30753379.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    20. Lewy Body Dementia Association's Research Centers of Excellence Program: Inaugural Meeting Proceedings. Alzheimers Res Ther. 2019 03 13; 11(1):23. Peterson B, Armstrong M, Galasko D, Galvin JE, Goldman J, Irwin D, Paulson H, Kaufer D, Leverenz J, Lunde A, McKeith IG, Siderowf A, Taylor A, Amodeo K, Barrett M, Domoto-Reilly K, Duda J, Gomperts S, Graff-Radford N, Holden S, Honig L, Huddleston D, Lippa C, Litvan I, Manning C, Marder K, Moussa C, Onyike C, Pagan F, Pantelyat A, Pelak V, Poston K, Quinn J, Richard I, Rosenthal LS, Sabbagh M, Scharre D, Sha S, Shill H, Torres-Yaghi Y, Christie T, Graham T, Richards I, Koehler M, Boeve B. PMID: 30867052.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    21. Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aß, tau, immunity and lipid processing. Nat Genet. 2019 03; 51(3):414-430. Kunkle BW, Grenier-Boley B, Sims R, Bis JC, Damotte V, Naj AC, Boland A, Vronskaya M, van der Lee SJ, Amlie-Wolf A, Bellenguez C, Frizatti A, Chouraki V, Martin ER, Sleegers K, Badarinarayan N, Jakobsdottir J, Hamilton-Nelson KL, Moreno-Grau S, Olaso R, Raybould R, Chen Y, Kuzma AB, Hiltunen M, Morgan T, Ahmad S, Vardarajan BN, Epelbaum J, Hoffmann P, Boada M, Beecham GW, Garnier JG, Harold D, Fitzpatrick AL, Valladares O, Moutet ML, Gerrish A, Smith AV, Qu L, Bacq D, Denning N, Jian X, Zhao Y, Del Zompo M, Fox NC, Choi SH, Mateo I, Hughes JT, Adams HH, Malamon J, Sanchez-Garcia F, Patel Y, Brody JA, Dombroski BA, Naranjo MCD, Daniilidou M, Eiriksdottir G, Mukherjee S, Wallon D, Uphill J, Aspelund T, Cantwell LB, Garzia F, Galimberti D, Hofer E, Butkiewicz M, Fin B, Scarpini E, Sarnowski C, Bush WS, Meslage S, Kornhuber J, White CC, Song Y, Barber RC, Engelborghs S, Sordon S, Voijnovic D, Adams PM, Vandenberghe R, Mayhaus M, Cupples LA, Albert MS, De Deyn PP, Gu W, Himali JJ, Beekly D, Squassina A, Hartmann AM, Orellana A, Blacker D, Rodriguez-Rodriguez E, Lovestone S, Garcia ME, Doody RS, Munoz-Fernadez C, Sussams R, Lin H, Fairchild TJ, Benito YA, Holmes C, Karamujic-Comic H, Frosch MP, Thonberg H, Maier W, Roshchupkin G, Ghetti B, Giedraitis V, Kawalia A, Li S, Huebinger RM, Kilander L, Moebus S, Hernández I, Kamboh MI, Brundin R, Turton J, Yang Q, Katz MJ, Concari L, Lord J, Beiser AS, Keene CD, Helisalmi S, Kloszewska I, Kukull WA, Koivisto AM, Lynch A, Tarraga L, Larson EB, Haapasalo A, Lawlor B, Mosley TH, Lipton RB, Solfrizzi V, Gill M, Longstreth WT, Montine TJ, Frisardi V, Diez-Fairen M, Rivadeneira F, Petersen RC, Deramecourt V, Alvarez I, Salani F, Ciaramella A, Boerwinkle E, Reiman EM, Fievet N, Rotter JI, Reisch JS, Hanon O, Cupidi C, Andre Uitterlinden AG, Royall DR, Dufouil C, Maletta RG, de Rojas I, Sano M, Brice A, Cecchetti R, George-Hyslop PS, Ritchie K, Tsolaki M, Tsuang DW, Dubois B, Craig D, Wu CK, Soininen H, Avramidou D, Albin RL, Fratiglioni L, Germanou A, Apostolova LG, Keller L, Koutroumani M, Arnold SE, Panza F, Gkatzima O, Asthana S, Hannequin D, Whitehead P, Atwood CS, Caffarra P, Hampel H, Quintela I, Carracedo Á, Lannfelt L, Rubinsztein DC, Barnes LL, Pasquier F, Frölich L, Barral S, McGuinness B, Beach TG, Johnston JA, Becker JT, Passmore P, Bigio EH, Schott JM, Bird TD, Warren JD, Boeve BF, Lupton MK, Bowen JD, Proitsi P, Boxer A, Powell JF, Burke JR, Kauwe JSK, Burns JM, Mancuso M, Buxbaum JD, Bonuccelli U, Cairns NJ, McQuillin A, Cao C, Livingston G, Carlson CS, Bass NJ, Carlsson CM, Hardy J, Carney RM, Bras J, Carrasquillo MM, Guerreiro R, Allen M, Chui HC, Fisher E, Masullo C, Crocco EA, DeCarli C, Bisceglio G, Dick M, Ma L, Duara R, Graff-Radford NR, Evans DA, Hodges A, Faber KM, Scherer M, Fallon KB, Riemenschneider M, Fardo DW, Heun R, Farlow MR, Kölsch H, Ferris S, Leber M, Foroud TM, Heuser I, Galasko DR, Giegling I, Gearing M, Hüll M, Geschwind DH, Gilbert JR, Morris J, Green RC, Mayo K, Growdon JH, Feulner T, Hamilton RL, Harrell LE, Drichel D, Honig LS, Cushion TD, Huentelman MJ, Hollingworth P, Hulette CM, Hyman BT, Marshall R, Jarvik GP, Meggy A, Abner E, Menzies GE, Jin LW, Leonenko G, Real LM, Jun GR, Baldwin CT, Grozeva D, Karydas A, Russo G, Kaye JA, Kim R, Jessen F, Kowall NW, Vellas B, Kramer JH, Vardy E, LaFerla FM, Jöckel KH, Lah JJ, Dichgans M, Leverenz JB, Mann D, Levey AI, Pickering-Brown S, Lieberman AP, Klopp N, Lunetta KL, Wichmann HE, Lyketsos CG, Morgan K, Marson DC, Brown K, Martiniuk F, Medway C, Mash DC, Nöthen MM, Masliah E, Hooper NM, McCormick WC, Daniele A, McCurry SM, Bayer A, McDavid AN, Gallacher J, McKee AC, van den Bussche H, Mesulam M, Brayne C, Miller BL, Riedel-Heller S, Miller CA, Miller JW, Al-Chalabi A, Morris JC, Shaw CE, Myers AJ, Wiltfang J, O'Bryant S, Olichney JM, Alvarez V, Parisi JE, Singleton AB, Paulson HL, Collinge J, Perry WR, Mead S, Peskind E, Cribbs DH, Rossor M, Pierce A, Ryan NS, Poon WW, Nacmias B, Potter H, Sorbi S, et al. PMID: 30820047.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    22. Comparison of Pittsburgh compound B and florbetapir in cross-sectional and longitudinal studies. Alzheimers Dement (Amst). 2019 Dec; 11:180-190. Su Y, Flores S, Wang G, Hornbeck RC, Speidel B, Joseph-Mathurin N, Vlassenko AG, Gordon BA, Koeppe RA, Klunk WE, Jack CR, Farlow MR, Salloway S, Snider BJ, Berman SB, Roberson ED, Brosch J, Jimenez-Velazques I, van Dyck CH, Galasko D, Yuan SH, Jayadev S, Honig LS, Gauthier S, Hsiung GR, Masellis M, Brooks WS, Fulham M, Clarnette R, Masters CL, Wallon D, Hannequin D, Dubois B, Pariente J, Sanchez-Valle R, Mummery C, Ringman JM, Bottlaender M, Klein G, Milosavljevic-Ristic S, McDade E, Xiong C, Morris JC, Bateman RJ, Benzinger TLS. PMID: 30847382.
      View in: PubMed   Mentions:
    23. Early versus late MCI: Improved MCI staging using a neuropsychological approach. Alzheimers Dement. 2019 05; 15(5):699-708. Edmonds EC, McDonald CR, Marshall A, Thomas KR, Eppig J, Weigand AJ, Delano-Wood L, Galasko DR, Salmon DP, Bondi MW. PMID: 30737119.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    24. Feasibility and safety of lumbar puncture in the Parkinson's disease research participants: Parkinson's Progression Marker Initiative (PPMI). Parkinsonism Relat Disord. 2019 05; 62:201-209. Prakash N, Caspell-Garcia C, Coffey C, Siderowf A, Tanner CM, Kieburtz K, Mollenhauer B, Galasko D, Merchant K, Foroud T, Chahine LM, Weintraub D, Casaceli C, Dorsey R, Wilson R, Herzog M, Daegele N, Arnedo V, Frasier M, Sherer T, Marek K, Frank S, Jennings D, Simuni T. PMID: 30738748.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    25. Artificially low mild cognitive impairment to normal reversion rate in the Alzheimer's Disease Neuroimaging Initiative. Alzheimers Dement. 2019 04; 15(4):561-569. Thomas KR, Eppig JS, Weigand AJ, Edmonds EC, Wong CG, Jak AJ, Delano-Wood L, Galasko DR, Salmon DP, Edland SD, Bondi MW. PMID: 30610833.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    26. Alzheimer's disease and the processing of uncertainty during choice task performance: Executive dysfunction within the Hick-Hyman law. J Clin Exp Neuropsychol. 2019 05; 41(4):380-389. Korthauer LE, Salmon DP, Festa EK, Galasko D, Heindel WC. PMID: 30632903.
      View in: PubMed   Mentions:    Fields:    
    27. Neuropsychological Deficit Profiles, Vascular Risk Factors, and Neuropathological Findings in Hispanic Older Adults with Autopsy-Confirmed Alzheimer's Disease. J Alzheimers Dis. 2019; 67(1):291-302. Weissberger GH, Gollan TH, Bondi MW, Nation DA, Hansen LA, Galasko D, Salmon DP. PMID: 30636736.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    28. Validation of MicroRNA Biomarkers for Alzheimer's Disease in Human Cerebrospinal Fluid. J Alzheimers Dis. 2019; 67(3):875-891. Wiedrick JT, Phillips JI, Lusardi TA, McFarland TJ, Lind B, Sandau US, Harrington CA, Lapidus JA, Galasko DR, Quinn JF, Saugstad JA. PMID: 30689565.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    29. Predicting Progression in Parkinson's Disease Using Baseline and 1-Year Change Measures. J Parkinsons Dis. 2019; 9(4):665-679. Chahine LM, Siderowf A, Barnes J, Seedorff N, Caspell-Garcia C, Simuni T, Coffey CS, Galasko D, Mollenhauer B, Arnedo V, Daegele N, Frasier M, Tanner C, Kieburtz K, Marek K. PMID: 31450510.
      View in: PubMed   Mentions:    Fields:    
    30. Alzheimer's disease: The right drug, the right time. Science. 2018 12 14; 362(6420):1250-1251. Golde TE, DeKosky ST, Galasko D. PMID: 30545877.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    31. Trajectories of cognitive decline differ in hippocampal sclerosis and Alzheimer's disease. Neurobiol Aging. 2019 03; 75:169-177. Smirnov DS, Galasko D, Hansen LA, Edland SD, Brewer JB, Salmon DP. PMID: 30579145.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    32. Learnings about the complexity of extracellular tau aid development of a blood-based screen for Alzheimer's disease. Alzheimers Dement. 2019 03; 15(3):487-496. Chen Z, Mengel D, Keshavan A, Rissman RA, Billinton A, Perkinton M, Percival-Alwyn J, Schultz A, Properzi M, Johnson K, Selkoe DJ, Sperling RA, Patel P, Zetterberg H, Galasko D, Schott JM, Walsh DM. PMID: 30419228.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    33. The Parkinson's progression markers initiative (PPMI) - establishing a PD biomarker cohort. Ann Clin Transl Neurol. 2018 Dec; 5(12):1460-1477. Marek K, Chowdhury S, Siderowf A, Lasch S, Coffey CS, Caspell-Garcia C, Simuni T, Jennings D, Tanner CM, Trojanowski JQ, Shaw LM, Seibyl J, Schuff N, Singleton A, Kieburtz K, Toga AW, Mollenhauer B, Galasko D, Chahine LM, Weintraub D, Foroud T, Tosun-Turgut D, Poston K, Arnedo V, Frasier M, Sherer T. PMID: 30564614.
      View in: PubMed   Mentions: 6     Fields:    
    34. A comprehensive screening of copy number variability in dementia with Lewy bodies. Neurobiol Aging. 2019 03; 75:223.e1-223.e10. Kun-Rodrigues C, Orme T, Carmona S, Hernandez DG, Ross OA, Eicher JD, Shepherd C, Parkkinen L, Darwent L, Heckman MG, Scholz SW, Troncoso JC, Pletnikova O, Dawson T, Rosenthal L, Ansorge O, Clarimon J, Lleo A, Morenas-Rodriguez E, Clark L, Honig LS, Marder K, Lemstra A, Rogaeva E, St George-Hyslop P, Londos E, Zetterberg H, Barber I, Braae A, Brown K, Morgan K, Troakes C, Al-Sarraj S, Lashley T, Holton J, Compta Y, Van Deerlin V, Serrano GE, Beach TG, Lesage S, Galasko D, Masliah E, Santana I, Pastor P, Diez-Fairen M, Aguilar M, Tienari PJ, Myllykangas L, Oinas M, Revesz T, Lees A, Boeve BF, Petersen RC, Ferman TJ, Escott-Price V, Graff-Radford N, Cairns NJ, Morris JC, Pickering-Brown S, Mann D, Halliday GM, Hardy J, Trojanowski JQ, Dickson DW, Singleton A, Stone DJ, Guerreiro R, Bras J. PMID: 30448004.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    35. Appropriate use criteria for lumbar puncture and cerebrospinal fluid testing in the diagnosis of Alzheimer's disease. Alzheimers Dement. 2018 11; 14(11):1505-1521. Shaw LM, Arias J, Blennow K, Galasko D, Molinuevo JL, Salloway S, Schindler S, Carrillo MC, Hendrix JA, Ross A, Illes J, Ramus C, Fifer S. PMID: 30316776.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    36. Version 3 of the National Alzheimer's Coordinating Center's Uniform Data Set. Alzheimer Dis Assoc Disord. 2018 Oct-Dec; 32(4):351-358. Besser L, Kukull W, Knopman DS, Chui H, Galasko D, Weintraub S, Jicha G, Carlsson C, Burns J, Quinn J, Sweet RA, Rascovsky K, Teylan M, Beekly D, Thomas G, Bollenbeck M, Monsell S, Mock C, Zhou XH, Thomas N, Robichaud E, Dean M, Hubbard J, Jacka M, Schwabe-Fry K, Wu J, Phelps C, Morris JC. PMID: 30376508.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    37. Microstructural brain changes track cognitive decline in mild cognitive impairment. Neuroimage Clin. 2018; 20:883-891. Reas ET, Hagler DJ, White NS, Kuperman JM, Bartsch H, Wierenga CE, Galasko D, Brewer JB, Dale AM, McEvoy LK. PMID: 30290303.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    38. Subjective Cognitive Decline Correlates With Depression Symptoms and Not With Concurrent Objective Cognition in a Clinic-Based Sample of Older Adults. J Gerontol B Psychol Sci Soc Sci. 2018 09 20; 73(7):1198-1202. Zlatar ZZ, Muniz M, Galasko D, Salmon DP. PMID: 28329816.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    39. Increasing Inaccuracy of Self-Reported Subjective Cognitive Complaints Over 24 Months in Empirically Derived Subtypes of Mild Cognitive Impairment. J Int Neuropsychol Soc. 2018 09; 24(8):842-853. Edmonds EC, Weigand AJ, Thomas KR, Eppig J, Delano-Wood L, Galasko DR, Salmon DP, Bondi MW. PMID: 30278855.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    40. a-Synuclein oligomers induce early axonal dysfunction in human iPSC-based models of synucleinopathies. Proc Natl Acad Sci U S A. 2018 07 24; 115(30):7813-7818. Prots I, Grosch J, Brazdis RM, Simmnacher K, Veber V, Havlicek S, Hannappel C, Krach F, Krumbiegel M, Schütz O, Reis A, Wrasidlo W, Galasko DR, Groemer TW, Masliah E, Schlötzer-Schrehardt U, Xiang W, Winkler J, Winner B. PMID: 29991596.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    41. Primary brain calcification: an international study reporting novel variants and associated phenotypes. Eur J Hum Genet. 2018 10; 26(10):1462-1477. Ramos EM, Carecchio M, Lemos R, Ferreira J, Legati A, Sears RL, Hsu SC, Panteghini C, Magistrelli L, Salsano E, Esposito S, Taroni F, Richard AC, Tranchant C, Anheim M, Ayrignac X, Goizet C, Vidailhet M, Maltete D, Wallon D, Frebourg T, Pimentel L, Geschwind DH, Vanakker O, Galasko D, Fogel BL, Innes AM, Ross A, Dobyns WB, Alcantara D, O'Driscoll M, Hannequin D, Campion D, Oliveira JR, Garavaglia B, Coppola G, Nicolas G. PMID: 29955172.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    42. Preferential degradation of cognitive networks differentiates Alzheimer's disease from ageing. Brain. 2018 05 01; 141(5):1486-1500. Chhatwal JP, Schultz AP, Johnson KA, Hedden T, Jaimes S, Benzinger TLS, Jack C, Ances BM, Ringman JM, Marcus DS, Ghetti B, Farlow MR, Danek A, Levin J, Yakushev I, Laske C, Koeppe RA, Galasko DR, Xiong C, Masters CL, Schofield PR, Kinnunen KM, Salloway S, Martins RN, McDade E, Cairns NJ, Buckles VD, Morris JC, Bateman R, Sperling RA. PMID: 29522171.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    43. Longitudinal Change of Clinical and Biological Measures in Early Parkinson's Disease: Parkinson's Progression Markers Initiative Cohort. Mov Disord. 2018 05; 33(5):771-782. Simuni T, Siderowf A, Lasch S, Coffey CS, Caspell-Garcia C, Jennings D, Tanner CM, Trojanowski JQ, Shaw LM, Seibyl J, Schuff N, Singleton A, Kieburtz K, Toga AW, Mollenhauer B, Galasko D, Chahine LM, Weintraub D, Foroud T, Tosun D, Poston K, Arnedo V, Frasier M, Sherer T, Chowdhury S, Marek K. PMID: 29572948.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    44. APOE DNA methylation is altered in Lewy body dementia. Alzheimers Dement. 2018 07; 14(7):889-894. Tulloch J, Leong L, Chen S, Keene CD, Millard SP, Shutes-David A, Lopez OL, Kofler J, Kaye JA, Woltjer R, Nelson PT, Neltner JH, Jicha GA, Galasko D, Masliah E, Leverenz JB, Yu CE, Tsuang D. PMID: 29544979.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    45. Associations between CSF cortisol and CSF norepinephrine in cognitively normal controls and patients with amnestic MCI and AD dementia. Int J Geriatr Psychiatry. 2018 05; 33(5):763-768. Wang LY, Raskind MA, Wilkinson CW, Shofer JB, Sikkema C, Szot P, Quinn JF, Galasko DR, Peskind ER. PMID: 29446123.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    46. Rapid and ultra-sensitive quantitation of disease-associated a-synuclein seeds in brain and cerebrospinal fluid by aSyn RT-QuIC. Acta Neuropathol Commun. 2018 02 09; 6(1):7. Groveman BR, Orrù CD, Hughson AG, Raymond LD, Zanusso G, Ghetti B, Campbell KJ, Safar J, Galasko D, Caughey B. PMID: 29422107.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    47. Autophagy inhibition promotes SNCA/alpha-synuclein release and transfer via extracellular vesicles with a hybrid autophagosome-exosome-like phenotype. Autophagy. 2018; 14(1):98-119. Minakaki G, Menges S, Kittel A, Emmanouilidou E, Schaeffner I, Barkovits K, Bergmann A, Rockenstein E, Adame A, Marxreiter F, Mollenhauer B, Galasko D, Buzás EI, Schlötzer-Schrehardt U, Marcus K, Xiang W, Lie DC, Vekrellis K, Masliah E, Winkler J, Klucken J. PMID: 29198173.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansAnimalsCells
    48. Sex Influences the Accuracy of Subjective Memory Complaint Reporting in Older Adults. J Alzheimers Dis. 2018; 61(3):1163-1178. Sundermann EE, Edmonds EC, Delano-Wood L, Galasko DR, Salmon DP, Rubin LH, Bondi MW. PMID: 29332038.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    49. Subjective Cognitive Decline, Objective Cognition, and Depression in Older Hispanics Screened for Memory Impairment. J Alzheimers Dis. 2018; 63(3):949-956. Zlatar ZZ, Muniz MC, Espinoza SG, Gratianne R, Gollan TH, Galasko D, Salmon DP. PMID: 29689718.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    50. Clinical-Neuropathological Correlations of Alzheimer's Disease and Related Dementias in Latino Volunteers. J Alzheimers Dis. 2018; 66(4):1539-1548. Soria JA, Huisa BN, Edland SD, Litvan I, Peavy GM, Salmon DP, Hansen LA, Galasko DR, Brewer JB, González HM, Rissman RA. PMID: 30412501.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    51. A Longitudinal Study of Total and Phosphorylated a-Synuclein with Other Biomarkers in Cerebrospinal Fluid of Alzheimer's Disease and Mild Cognitive Impairment. J Alzheimers Dis. 2018; 61(4):1541-1553. Wang H, Stewart T, Toledo JB, Ginghina C, Tang L, Atik A, Aro P, Shaw LM, Trojanowski JQ, Galasko DR, Edland S, Jensen PH, Shi M, Zhang J. PMID: 29376878.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    52. Investigating the genetic architecture of dementia with Lewy bodies: a two-stage genome-wide association study. Lancet Neurol. 2018 01; 17(1):64-74. Guerreiro R, Ross OA, Kun-Rodrigues C, Hernandez DG, Orme T, Eicher JD, Shepherd CE, Parkkinen L, Darwent L, Heckman MG, Scholz SW, Troncoso JC, Pletnikova O, Ansorge O, Clarimon J, Lleo A, Morenas-Rodriguez E, Clark L, Honig LS, Marder K, Lemstra A, Rogaeva E, St George-Hyslop P, Londos E, Zetterberg H, Barber I, Braae A, Brown K, Morgan K, Troakes C, Al-Sarraj S, Lashley T, Holton J, Compta Y, Van Deerlin V, Serrano GE, Beach TG, Lesage S, Galasko D, Masliah E, Santana I, Pastor P, Diez-Fairen M, Aguilar M, Tienari PJ, Myllykangas L, Oinas M, Revesz T, Lees A, Boeve BF, Petersen RC, Ferman TJ, Escott-Price V, Graff-Radford N, Cairns NJ, Morris JC, Pickering-Brown S, Mann D, Halliday GM, Hardy J, Trojanowski JQ, Dickson DW, Singleton A, Stone DJ, Bras J. PMID: 29263008.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    53. Unmasking the benefits of donepezil via psychometrically precise identification of mild cognitive impairment: A secondary analysis of the ADCS vitamin E and donepezil in MCI study. Alzheimers Dement (N Y). 2018; 4:11-18. Edmonds EC, Ard MC, Edland SD, Galasko DR, Salmon DP, Bondi MW. PMID: 29296659.
      View in: PubMed   Mentions:
    54. Longitudinal CSF biomarkers in patients with early Parkinson disease and healthy controls. Neurology. 2017 Nov 07; 89(19):1959-1969. Mollenhauer B, Caspell-Garcia CJ, Coffey CS, Taylor P, Shaw LM, Trojanowski JQ, Singleton A, Frasier M, Marek K, Galasko D. PMID: 29030452.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    55. Potential implications of practice effects in Alzheimer's disease prevention trials. Alzheimers Dement (N Y). 2017 Nov; 3(4):531-535. Jacobs DM, Ard MC, Salmon DP, Galasko DR, Bondi MW, Edland SD. PMID: 29124111.
      View in: PubMed   Mentions:
    56. Sensitivity of restriction spectrum imaging to memory and neuropathology in Alzheimer's disease. Alzheimers Res Ther. 2017 Aug 02; 9(1):55. Reas ET, Hagler DJ, White NS, Kuperman JM, Bartsch H, Cross K, Loi RQ, Balachandra AR, Meloy MJ, Wierenga CE, Galasko D, Brewer JB, Dale AM, McEvoy LK. PMID: 28764771.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    57. A user's guide for a-synuclein biomarker studies in biological fluids: Perianalytical considerations. Mov Disord. 2017 Aug; 32(8):1117-1130. Mollenhauer B, Batrla R, El-Agnaf O, Galasko DR, Lashuel HA, Merchant KM, Shaw LM, Selkoe DJ, Umek R, Vanderstichele H, Zetterberg H, Zhang J, Caspell-Garcia C, Coffey C, Hutten SJ, Frasier M, Taylor P. PMID: 28734051.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    58. Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease. Nat Genet. 2017 09; 49(9):1373-1384. Sims R, van der Lee SJ, Naj AC, Bellenguez C, Badarinarayan N, Jakobsdottir J, Kunkle BW, Boland A, Raybould R, Bis JC, Martin ER, Grenier-Boley B, Heilmann-Heimbach S, Chouraki V, Kuzma AB, Sleegers K, Vronskaya M, Ruiz A, Graham RR, Olaso R, Hoffmann P, Grove ML, Vardarajan BN, Hiltunen M, Nöthen MM, White CC, Hamilton-Nelson KL, Epelbaum J, Maier W, Choi SH, Beecham GW, Dulary C, Herms S, Smith AV, Funk CC, Derbois C, Forstner AJ, Ahmad S, Li H, Bacq D, Harold D, Satizabal CL, Valladares O, Squassina A, Thomas R, Brody JA, Qu L, Sánchez-Juan P, Morgan T, Wolters FJ, Zhao Y, Garcia FS, Denning N, Fornage M, Malamon J, Naranjo MCD, Majounie E, Mosley TH, Dombroski B, Wallon D, Lupton MK, Dupuis J, Whitehead P, Fratiglioni L, Medway C, Jian X, Mukherjee S, Keller L, Brown K, Lin H, Cantwell LB, Panza F, McGuinness B, Moreno-Grau S, Burgess JD, Solfrizzi V, Proitsi P, Adams HH, Allen M, Seripa D, Pastor P, Cupples LA, Price ND, Hannequin D, Frank-García A, Levy D, Chakrabarty P, Caffarra P, Giegling I, Beiser AS, Giedraitis V, Hampel H, Garcia ME, Wang X, Lannfelt L, Mecocci P, Eiriksdottir G, Crane PK, Pasquier F, Boccardi V, Henández I, Barber RC, Scherer M, Tarraga L, Adams PM, Leber M, Chen Y, Albert MS, Riedel-Heller S, Emilsson V, Beekly D, Braae A, Schmidt R, Blacker D, Masullo C, Schmidt H, Doody RS, Spalletta G, Longstreth WT, Fairchild TJ, Bossù P, Lopez OL, Frosch MP, Sacchinelli E, Ghetti B, Yang Q, Huebinger RM, Jessen F, Li S, Kamboh MI, Morris J, Sotolongo-Grau O, Katz MJ, Corcoran C, Dunstan M, Braddel A, Thomas C, Meggy A, Marshall R, Gerrish A, Chapman J, Aguilar M, Taylor S, Hill M, Fairén MD, Hodges A, Vellas B, Soininen H, Kloszewska I, Daniilidou M, Uphill J, Patel Y, Hughes JT, Lord J, Turton J, Hartmann AM, Cecchetti R, Fenoglio C, Serpente M, Arcaro M, Caltagirone C, Orfei MD, Ciaramella A, Pichler S, Mayhaus M, Gu W, Lleó A, Fortea J, Blesa R, Barber IS, Brookes K, Cupidi C, Maletta RG, Carrell D, Sorbi S, Moebus S, Urbano M, Pilotto A, Kornhuber J, Bosco P, Todd S, Craig D, Johnston J, Gill M, Lawlor B, Lynch A, Fox NC, Hardy J, Albin RL, Apostolova LG, Arnold SE, Asthana S, Atwood CS, Baldwin CT, Barnes LL, Barral S, Beach TG, Becker JT, Bigio EH, Bird TD, Boeve BF, Bowen JD, Boxer A, Burke JR, Burns JM, Buxbaum JD, Cairns NJ, Cao C, Carlson CS, Carlsson CM, Carney RM, Carrasquillo MM, Carroll SL, Diaz CC, Chui HC, Clark DG, Cribbs DH, Crocco EA, DeCarli C, Dick M, Duara R, Evans DA, Faber KM, Fallon KB, Fardo DW, Farlow MR, Ferris S, Foroud TM, Galasko DR, Gearing M, Geschwind DH, Gilbert JR, Graff-Radford NR, Green RC, Growdon JH, Hamilton RL, Harrell LE, Honig LS, Huentelman MJ, Hulette CM, Hyman BT, Jarvik GP, Abner E, Jin LW, Jun G, Karydas A, Kaye JA, Kim R, Kowall NW, Kramer JH, LaFerla FM, Lah JJ, Leverenz JB, Levey AI, Li G, Lieberman AP, Lunetta KL, Lyketsos CG, Marson DC, Martiniuk F, Mash DC, Masliah E, McCormick WC, McCurry SM, McDavid AN, McKee AC, Mesulam M, Miller BL, Miller CA, Miller JW, Morris JC, Murrell JR, Myers AJ, O'Bryant S, Olichney JM, Pankratz VS, Parisi JE, Paulson HL, Perry W, Peskind E, Pierce A, Poon WW, Potter H, Quinn JF, Raj A, Raskind M, Reisberg B, Reitz C, Ringman JM, Roberson ED, Rogaeva E, Rosen HJ, Rosenberg RN, Sager MA, Saykin AJ, Schneider JA, Schneider LS, Seeley WW, Smith AG, Sonnen JA, Spina S, Stern RA, Swerdlow RH, Tanzi RE, Thornton-Wells TA, Trojanowski JQ, Troncoso JC, Van Deerlin VM, Van Eldik LJ, Vinters HV, Vonsattel JP, Weintraub S, Welsh-Bohmer KA, Wilhelmsen KC, Williamson J, Wingo TS, Woltjer RL, Wright CB, Yu CE, Yu L, Garzia F, Golamaully F, Septier G, Engelborghs S, Vandenberghe R, De Deyn PP, Fernadez CM, Benito YA, Thonberg H, Forsell C, Lilius L, Kinhult-Stählbom A, Kilander L, Brundin R, Concari L, Helisalmi S, Koivisto AM, Haapasalo A, Dermecourt V, Fievet N, Hanon O, Dufouil C, Brice A, Ritchie K, Dubois B, Himali JJ, Keene CD, Tschanz J, Fitzpatrick AL, Kukull WA, Norton M, Aspelund T, Larson EB, Munger R, Rotter JI, et al. PMID: 28714976.
      View in: PubMed   Mentions: 84     Fields:    Translation:HumansCells
    59. Cerebrospinal fluid biomarkers for Alzheimer's and vascular disease vary by age, gender, and APOE genotype in cognitively normal adults. Alzheimers Res Ther. 2017 Jul 03; 9(1):48. Li G, Shofer JB, Petrie EC, Yu CE, Wilkinson CW, Figlewicz DP, Shutes-David A, Zhang J, Montine TJ, Raskind MA, Quinn JF, Galasko DR, Peskind ER. PMID: 28673336.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    60. Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium. Neurology. 2017 Jul 04; 89(1):88-100. McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor JP, Weintraub D, Aarsland D, Galvin J, Attems J, Ballard CG, Bayston A, Beach TG, Blanc F, Bohnen N, Bonanni L, Bras J, Brundin P, Burn D, Chen-Plotkin A, Duda JE, El-Agnaf O, Feldman H, Ferman TJ, Ffytche D, Fujishiro H, Galasko D, Goldman JG, Gomperts SN, Graff-Radford NR, Honig LS, Iranzo A, Kantarci K, Kaufer D, Kukull W, Lee VMY, Leverenz JB, Lewis S, Lippa C, Lunde A, Masellis M, Masliah E, McLean P, Mollenhauer B, Montine TJ, Moreno E, Mori E, Murray M, O'Brien JT, Orimo S, Postuma RB, Ramaswamy S, Ross OA, Salmon DP, Singleton A, Taylor A, Thomas A, Tiraboschi P, Toledo JB, Trojanowski JQ, Tsuang D, Walker Z, Yamada M, Kosaka K. PMID: 28592453.
      View in: PubMed   Mentions: 205     Fields:    Translation:Humans
    61. A cerebrospinal fluid microRNA signature as biomarker for glioblastoma. Oncotarget. 2017 Sep 15; 8(40):68769-68779. Akers JC, Hua W, Li H, Ramakrishnan V, Yang Z, Quan K, Zhu W, Li J, Figueroa J, Hirshman BR, Miller B, Piccioni D, Ringel F, Komotar R, Messer K, Galasko DR, Hochberg F, Mao Y, Carter BS, Chen CC. PMID: 28978155.
      View in: PubMed   Mentions: 10     Fields:    
    62. Analysis of extracellular RNA in cerebrospinal fluid. J Extracell Vesicles. 2017; 6(1):1317577. Saugstad JA, Lusardi TA, Van Keuren-Jensen KR, Phillips JI, Lind B, Harrington CA, McFarland TJ, Courtright AL, Reiman RA, Yeri AS, Kalani MYS, Adelson PD, Arango J, Nolan JP, Duggan E, Messer K, Akers JC, Galasko DR, Quinn JF, Carter BS, Hochberg FH. PMID: 28717417.
      View in: PubMed   Mentions:
    63. Searching for Neurodegeneration in the Blood of Patients With Alzheimer Disease. JAMA Neurol. 2017 05 01; 74(5):510-511. Galasko D. PMID: 28346580.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    64. Lewy Body Disorders. Neurol Clin. 2017 05; 35(2):325-338. Galasko D. PMID: 28410662.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    65. Decreased body mass index in the preclinical stage of autosomal dominant Alzheimer's disease. Sci Rep. 2017 04 27; 7(1):1225. Müller S, Preische O, Sohrabi HR, Gräber S, Jucker M, Dietzsch J, Ringman JM, Martins RN, McDade E, Schofield PR, Ghetti B, Rossor M, Graff-Radford NR, Levin J, Galasko D, Quaid KA, Salloway S, Xiong C, Benzinger T, Buckles V, Masters CL, Sperling R, Bateman RJ, Morris JC, Laske C. PMID: 28450713.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    66. NPTX2 and cognitive dysfunction in Alzheimer's Disease. Elife. 2017 03 23; 6. Xiao MF, Xu D, Craig MT, Pelkey KA, Chien CC, Shi Y, Zhang J, Resnick S, Pletnikova O, Salmon D, Brewer J, Edland S, Wegiel J, Tycko B, Savonenko A, Reeves RH, Troncoso JC, McBain CJ, Galasko D, Worley PF. PMID: 28440221.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimals
    67. Consensus classification of posterior cortical atrophy. Alzheimers Dement. 2017 Aug; 13(8):870-884. Crutch SJ, Schott JM, Rabinovici GD, Murray M, Snowden JS, van der Flier WM, Dickerson BC, Vandenberghe R, Ahmed S, Bak TH, Boeve BF, Butler C, Cappa SF, Ceccaldi M, de Souza LC, Dubois B, Felician O, Galasko D, Graff-Radford J, Graff-Radford NR, Hof PR, Krolak-Salmon P, Lehmann M, Magnin E, Mendez MF, Nestor PJ, Onyike CU, Pelak VS, Pijnenburg Y, Primativo S, Rossor MN, Ryan NS, Scheltens P, Shakespeare TJ, Suárez González A, Tang-Wai DF, Yong KXX, Carrillo M, Fox NC. PMID: 28259709.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    68. Tau oligomers in cerebrospinal fluid in Alzheimer's disease. Ann Clin Transl Neurol. 2017 04; 4(4):226-235. Sengupta U, Portelius E, Hansson O, Farmer K, Castillo-Carranza D, Woltjer R, Zetterberg H, Galasko D, Blennow K, Kayed R. PMID: 28382304.
      View in: PubMed   Mentions: 8     Fields:    
    69. Mass-Spectrometry-Based Method To Quantify in Parallel Tau and Amyloid ß 1-42 in CSF for the Diagnosis of Alzheimer's Disease. J Proteome Res. 2017 03 03; 16(3):1228-1238. Pottiez G, Yang L, Stewart T, Song N, Aro P, Galasko DR, Quinn JF, Peskind ER, Shi M, Zhang J. PMID: 28112948.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    70. Alzheimer disease: CSF biomarkers for Alzheimer disease - approaching consensus. Nat Rev Neurol. 2017 03; 13(3):131-132. Galasko DR, Shaw LM. PMID: 28155892.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    71. Dependence Levels as Interim Clinical Milestones Along the Continuum of Alzheimer's Disease: 18-Month Results from the GERAS Observational Study. J Prev Alzheimers Dis. 2017; 4(2):72-80. Kahle-Wrobleski K, Andrews JS, Belger M, Ye W, Gauthier S, Rentz DM, Galasko D. PMID: 29186278.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    72. Hippocampal a-Synuclein in Dementia with Lewy Bodies Contributes to Memory Impairment and Is Consistent with Spread of Pathology. J Neurosci. 2017 02 15; 37(7):1675-1684. Adamowicz DH, Roy S, Salmon DP, Galasko DR, Hansen LA, Masliah E, Gage FH. PMID: 28039370.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    73. Circadian alterations during early stages of Alzheimer's disease are associated with aberrant cycles of DNA methylation in BMAL1. Alzheimers Dement. 2017 Jun; 13(6):689-700. Cronin P, McCarthy MJ, Lim ASP, Salmon DP, Galasko D, Masliah E, De Jager PL, Bennett DA, Desplats P. PMID: 27883893.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    74. Correction: Quantitative Amyloid Imaging in Autosomal Dominant Alzheimer's Disease: Results from the DIAN Study Group. PLoS One. 2016; 11(9):e0163669. Su Y, Blazey TM, Owen CJ, Christensen JJ, Friedrichsen K, Joseph-Mathurin N, Wang Q, Hornbeck RC, Ances BM, Snyder AZ, Cash LA, Koeppe RA, Klunk WE, Galasko D, Brickman AM, McDade E, Ringman JM, Thompson PM, Saykin AJ, Ghetti B, Sperling RA, Johnson KA, Salloway SP, Schofield PR, Masters CL, Villemagne VL, Fox NC, Förster S, Chen K, Reiman EM, Xiong C, Marcus DS, Weiner MW, Morris JC, Bateman RJ, Benzinger TL. PMID: 27649320.
      View in: PubMed   Mentions: 1     Fields:    
    75. Analysis of C9orf72 repeat expansions in a large international cohort of dementia with Lewy bodies. Neurobiol Aging. 2017 01; 49:214.e13-214.e15. Kun-Rodrigues C, Ross OA, Orme T, Shepherd C, Parkkinen L, Darwent L, Hernandez D, Ansorge O, Clark LN, Honig LS, Marder K, Lemstra A, Scheltens P, van der Flier W, Louwersheimer E, Holstege H, Rogaeva E, St George-Hyslop P, Londos E, Zetterberg H, Barber I, Braae A, Brown K, Morgan K, Maetzler W, Berg D, Troakes C, Al-Sarraj S, Lashley T, Holton J, Compta Y, Van Deerlin V, Trojanowski JQ, Serrano GE, Beach TG, Clarimon J, Lleó A, Morenas-Rodríguez E, Lesage S, Galasko D, Masliah E, Santana I, Diez M, Pastor P, Tienari PJ, Myllykangas L, Oinas M, Revesz T, Lees A, Boeve BF, Petersen RC, Ferman TJ, Escott-Price V, Graff-Radford N, Cairns NJ, Morris JC, Stone DJ, Pickering-Brown S, Mann D, Dickson DW, Halliday GM, Singleton A, Guerreiro R, Bras J. PMID: 27666590.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    76. Arguing against the proposed definition changes of PD. Mov Disord. 2016 11; 31(11):1619-1622. Boeve BF, Dickson DW, Duda JE, Ferman TJ, Galasko DR, Galvin JE, Goldman JG, Growdon JH, Hurtig HI, Kaufer DI, Kantarci K, Leverenz JB, Lippa CF, Lopez OL, McKeith IG, Singleton AB, Taylor A, Tsuang D, Weintraub D, Zabetian CP. PMID: 27492190.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    77. Phenotypic differences based on staging of Alzheimer's neuropathology in autopsy-confirmed dementia with Lewy bodies. Parkinsonism Relat Disord. 2016 10; 31:72-78. Peavy GM, Edland SD, Toole BM, Hansen LA, Galasko DR, Mayo AM. PMID: 27475955.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    78. Visual Perceptual Organization Ability in Autopsy-Verified Dementia with Lewy Bodies and Alzheimer's Disease. J Int Neuropsychol Soc. 2016 07; 22(6):609-19. Mitolo M, Hamilton JM, Landy KM, Hansen LA, Galasko D, Pazzaglia F, Salmon DP. PMID: 27221597.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    79. CNS tau efflux via exosomes is likely increased in Parkinson's disease but not in Alzheimer's disease. Alzheimers Dement. 2016 11; 12(11):1125-1131. Shi M, Kovac A, Korff A, Cook TJ, Ginghina C, Bullock KM, Yang L, Stewart T, Zheng D, Aro P, Atik A, Kerr KF, Zabetian CP, Peskind ER, Hu SC, Quinn JF, Galasko DR, Montine TJ, Banks WA, Zhang J. PMID: 27234211.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansAnimalsCells
    80. Prediction of conversion from mild cognitive impairment to dementia with neuronally derived blood exosome protein profile. Alzheimers Dement (Amst). 2016; 3:63-72. Winston CN, Goetzl EJ, Akers JC, Carter BS, Rockenstein EM, Galasko D, Masliah E, Rissman RA. PMID: 27408937.
      View in: PubMed   Mentions:
    81. "Missed" Mild Cognitive Impairment: High False-Negative Error Rate Based on Conventional Diagnostic Criteria. J Alzheimers Dis. 2016 03 31; 52(2):685-91. Edmonds EC, Delano-Wood L, Jak AJ, Galasko DR, Salmon DP, Bondi MW. PMID: 27031477.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    82. CSF biomarkers associated with disease heterogeneity in early Parkinson's disease: the Parkinson's Progression Markers Initiative study. Acta Neuropathol. 2016 06; 131(6):935-49. Kang JH, Mollenhauer B, Coffey CS, Toledo JB, Weintraub D, Galasko DR, Irwin DJ, Van Deerlin V, Chen-Plotkin AS, Caspell-Garcia C, Waligórska T, Taylor P, Shah N, Pan S, Zero P, Frasier M, Marek K, Kieburtz K, Jennings D, Tanner CM, Simuni T, Singleton A, Toga AW, Chowdhury S, Trojanowski JQ, Shaw LM. PMID: 27021906.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    83. Quantitative Amyloid Imaging in Autosomal Dominant Alzheimer's Disease: Results from the DIAN Study Group. PLoS One. 2016; 11(3):e0152082. Su Y, Blazey TM, Owen CJ, Christensen JJ, Friedrichsen K, Joseph-Mathurin N, Wang Q, Hornbeck RC, Ances BM, Snyder AZ, Cash LA, Koeppe RA, Klunk WE, Galasko D, Brickman AM, McDade E, Ringman JM, Thompson PM, Saykin AJ, Ghetti B, Sperling RA, Johnson KA, Salloway SP, Schofield PR, Masters CL, Villemagne VL, Fox NC, Förster S, Chen K, Reiman EM, Xiong C, Marcus DS, Weiner MW, Morris JC, Bateman RJ, Benzinger TL. PMID: 27010959.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    84. Genetic risk factors for the posterior cortical atrophy variant of Alzheimer's disease. Alzheimers Dement. 2016 08; 12(8):862-71. Schott JM, Crutch SJ, Carrasquillo MM, Uphill J, Shakespeare TJ, Ryan NS, Yong KX, Lehmann M, Ertekin-Taner N, Graff-Radford NR, Boeve BF, Murray ME, Khan QU, Petersen RC, Dickson DW, Knopman DS, Rabinovici GD, Miller BL, González AS, Gil-Néciga E, Snowden JS, Harris J, Pickering-Brown SM, Louwersheimer E, van der Flier WM, Scheltens P, Pijnenburg YA, Galasko D, Sarazin M, Dubois B, Magnin E, Galimberti D, Scarpini E, Cappa SF, Hodges JR, Halliday GM, Bartley L, Carrillo MC, Bras JT, Hardy J, Rossor MN, Collinge J, Fox NC, Mead S. PMID: 26993346.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    85. Expanding the Repertoire of Biomarkers for Alzheimer's Disease: Targeted and Non-targeted Approaches. Front Neurol. 2015; 6:256. Galasko D. PMID: 26733934.
      View in: PubMed   Mentions:
    86. Motion discrimination in dementia with Lewy bodies and Alzheimer disease. Neurology. 2015 Oct 20; 85(16):1376-82. Landy KM, Salmon DP, Galasko D, Filoteo JV, Festa EK, Heindel WC, Hansen LA, Hamilton JM. PMID: 26400581.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    87. Visual search in Dementia with Lewy Bodies and Alzheimer's disease. Cortex. 2015 Dec; 73:228-39. Landy KM, Salmon DP, Filoteo JV, Heindel WC, Galasko D, Hamilton JM. PMID: 26476402.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    88. Modulation of Aß42 in vivo by ?-secretase modulator in primates and humans. Alzheimers Res Ther. 2015; 7(1):55. Ling IF, Golde TE, Galasko DR, Koo EH. PMID: 26244059.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCells
    89. Recognition memory span in autopsy-confirmed Dementia with Lewy Bodies and Alzheimer's Disease. Neuropsychologia. 2015 Aug; 75:548-55. Salmon DP, Heindel WC, Hamilton JM, Vincent Filoteo J, Cidambi V, Hansen LA, Masliah E, Galasko D. PMID: 26184443.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    90. Cerebrospinal Fluid Particles in Alzheimer Disease and Parkinson Disease. J Neuropathol Exp Neurol. 2015 Jul; 74(7):672-87. Yang Y, Keene CD, Peskind ER, Galasko DR, Hu SC, Cudaback E, Wilson AM, Li G, Yu CE, Montine KS, Zhang J, Baird GS, Hyman BT, Montine TJ. PMID: 26083568.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimalsCells
    91. Development of a patient-reported outcome instrument to assess complex activities of daily living and interpersonal functioning in persons with mild cognitive impairment: The qualitative research phase. Alzheimers Dement. 2016 Jan; 12(1):75-84. Gordon MF, Lenderking WR, Duhig A, Chandler J, Lundy JJ, Miller DS, Piault-Louis E, Doody RS, Galasko D, Gauthier S, Frank L. PMID: 26079412.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    92. Encouraging trends toward reduced risk of Alzheimer disease: What's good for the heart is good for the brain. Neurol Clin Pract. 2015 Jun; 5(3):190-192. Breitner JCS, Galasko D. PMID: 29443188.
      View in: PubMed   Mentions:
    93. Pulse pressure in relation to tau-mediated neurodegeneration, cerebral amyloidosis, and progression to dementia in very old adults. JAMA Neurol. 2015 May; 72(5):546-53. Nation DA, Edmonds EC, Bangen KJ, Delano-Wood L, Scanlon BK, Han SD, Edland SD, Salmon DP, Galasko DR, Bondi MW. PMID: 25822631.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    94. Rarity of the Alzheimer disease-protective APP A673T variant in the United States. JAMA Neurol. 2015 Feb; 72(2):209-16. Wang LS, Naj AC, Graham RR, Crane PK, Kunkle BW, Cruchaga C, Murcia JD, Cannon-Albright L, Baldwin CT, Zetterberg H, Blennow K, Kukull WA, Faber KM, Schupf N, Norton MC, Tschanz JT, Munger RG, Corcoran CD, Rogaeva E, Lin CF, Dombroski BA, Cantwell LB, Partch A, Valladares O, Hakonarson H, St George-Hyslop P, Green RC, Goate AM, Foroud TM, Carney RM, Larson EB, Behrens TW, Kauwe JS, Haines JL, Farrer LA, Pericak-Vance MA, Mayeux R, Schellenberg GD, Albert MS, Albin RL, Apostolova LG, Arnold SE, Barber R, Barmada M, Barnes LL, Beach TG, Becker JT, Beecham GW, Beekly D, Bennett DA, Bigio EH, Bird TD, Blacker D, Boeve BF, Bowen JD, Boxer A, Burke JR, Buxbaum JD, Cairns NJ, Cao C, Carlson CS, Carroll SL, Chui HC, Clark DG, Cribbs DH, Crocco EA, DeCarli C, DeKosky ST, Demirci FY, Dick M, Dickson DW, Duara R, Ertekin-Taner N, Fallon KB, Farlow MR, Ferris S, Frosch MP, Galasko DR, Ganguli M, Gearing M, Geschwind DH, Ghetti B, Gilbert JR, Glass JD, Graff-Radford NR, Growdon JH, Hamilton RL, Hamilton-Nelson KL, Harrell LE, Head E, Honig LS, Hulette CM, Hyman BT, Jarvik GP, Jicha GA, Jin LW, Jun G, Jun G, Kamboh MI, Karydas A, Kaye JA, Kim R, Koo EH, Kowall NW, Kramer JH, LaFerla FM, Lah JJ, Leverenz JB, Levey AI, Li G, Lieberman AP, Lopez OL, Lunetta KL, Lyketsos CG, Mack WJ, Marson DC, Martin ER, Martiniuk F, Mash DC, Masliah E, McCormick WC, McCurry SM, McDavid AN, McKee AC, Mesulam WM, Miller BL, Miller CA, Miller JW, Montine TJ, Morris JC, Murrell JR, Olichney JM, Parisi JE, Perry W, Peskind E, Petersen RC, Pierce A, Poon WW, Potter H, Quinn JF, Raj A, Raskind M, Reiman EM, Reisberg B, Reitz C, Ringman JM, Roberson ED, Rosen HJ, Rosenberg RN, Sano M, Saykin AJ, Schneider JA, Schneider LS, Seeley WW, Smith AG, Sonnen JA, Spina S, Stern RA, Tanzi RE, Thornton-Wells TA, Trojanowski JQ, Troncoso JC, Tsuang DW, Van Deerlin VM, Van Eldik LJ, Vardarajan BN, Vinters HV, Vonsattel JP, Weintraub S, Welsh-Bohmer KA, Williamson J, Wishnek S, Woltjer RL, Wright CB, Younkin SG, Yu CE, Yu L. PMID: 25531812.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    95. Clinical and Economic Characteristics of Milestones along the Continuum of Alzheimer's Disease: Transforming Functional Scores into Levels of Dependence. J Prev Alzheimers Dis. 2015; 2(2):115-120. Kahle-Wrobleski K, Andrews JS, Belger M, Gauthier S, Stern Y, Rentz DM, Galasko D. PMID: 28775969.
      View in: PubMed   Mentions: 2     Fields:    
    96. Cerebrospinal fluid peptides as potential Parkinson disease biomarkers: a staged pipeline for discovery and validation. Mol Cell Proteomics. 2015 Mar; 14(3):544-55. Shi M, Movius J, Dator R, Aro P, Zhao Y, Pan C, Lin X, Bammler TK, Stewart T, Zabetian CP, Peskind ER, Hu SC, Quinn JF, Galasko DR, Zhang J. PMID: 25556233.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    97. Increased CSF E-Selectin in Clinical Alzheimer's Disease without Altered CSF Aß42 and Tau. J Alzheimers Dis. 2015; 47(4):883-7. Li G, Xiong K, Korff A, Pan C, Quinn JF, Galasko DR, Liu C, Montine TJ, Peskind ER, Zhang J. PMID: 26401768.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    98. Subtle Cognitive Decline and Biomarker Staging in Preclinical Alzheimer's Disease. J Alzheimers Dis. 2015; 47(1):231-42. Edmonds EC, Delano-Wood L, Galasko DR, Salmon DP, Bondi MW. PMID: 26402771.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    99. Diagnostic Values of Cerebrospinal Fluid T-Tau and Aß42 using Meso Scale Discovery Assays for Alzheimer's Disease. J Alzheimers Dis. 2015; 45(3):709-19. Pan C, Korff A, Galasko D, Ginghina C, Peskind E, Li G, Quinn J, Montine TJ, Cain K, Shi M, Zhang J. PMID: 25613100.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    100. Cerebrospinal fluid a-synuclein and Lewy body-like symptoms in normal controls, mild cognitive impairment, and Alzheimer's disease. J Alzheimers Dis. 2015; 43(3):1007-16. Mackin RS, Insel P, Zhang J, Mohlenhoff B, Galasko D, Weiner M, Mattsson N. PMID: 25125463.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    101. Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association study. JAMA Neurol. 2014 Nov; 71(11):1394-404. Naj AC, Jun G, Reitz C, Kunkle BW, Perry W, Park YS, Beecham GW, Rajbhandary RA, Hamilton-Nelson KL, Wang LS, Kauwe JS, Huentelman MJ, Myers AJ, Bird TD, Boeve BF, Baldwin CT, Jarvik GP, Crane PK, Rogaeva E, Barmada MM, Demirci FY, Cruchaga C, Kramer PL, Ertekin-Taner N, Hardy J, Graff-Radford NR, Green RC, Larson EB, St George-Hyslop PH, Buxbaum JD, Evans DA, Schneider JA, Lunetta KL, Kamboh MI, Saykin AJ, Reiman EM, De Jager PL, Bennett DA, Morris JC, Montine TJ, Goate AM, Blacker D, Tsuang DW, Hakonarson H, Kukull WA, Foroud TM, Martin ER, Haines JL, Mayeux RP, Farrer LA, Schellenberg GD, Pericak-Vance MA, Albert MS, Albin RL, Apostolova LG, Arnold SE, Barber R, Barnes LL, Beach TG, Becker JT, Beekly D, Bigio EH, Bowen JD, Boxer A, Burke JR, Cairns NJ, Cantwell LB, Cao C, Carlson CS, Carney RM, Carrasquillo MM, Carroll SL, Chui HC, Clark DG, Corneveaux J, Cribbs DH, Crocco EA, DeCarli C, DeKosky ST, Dick M, Dickson DW, Duara R, Faber KM, Fallon KB, Farlow MR, Ferris S, Frosch MP, Galasko DR, Ganguli M, Gearing M, Geschwind DH, Ghetti B, Gilbert JR, Glass JD, Growdon JH, Hamilton RL, Harrell LE, Head E, Honig LS, Hulette CM, Hyman BT, Jicha GA, Jin LW, Karydas A, Kaye JA, Kim R, Koo EH, Kowall NW, Kramer JH, LaFerla FM, Lah JJ, Leverenz JB, Levey AI, Li G, Lieberman AP, Lin CF, Lopez OL, Lyketsos CG, Mack WJ, Martiniuk F, Mash DC, Masliah E, McCormick WC, McCurry SM, McDavid AN, McKee AC, Mesulam M, Miller BL, Miller CA, Miller JW, Murrell JR, Olichney JM, Pankratz VS, Parisi JE, Paulson HL, Peskind E, Petersen RC, Pierce A, Poon WW, Potter H, Quinn JF, Raj A, Raskind M, Reisberg B, Ringman JM, Roberson ED, Rosen HJ, Rosenberg RN, Sano M, Schneider LS, Seeley WW, Smith AG, Sonnen JA, Spina S, Stern RA, Tanzi RE, Thornton-Wells TA, Trojanowski JQ, Troncoso JC, Valladares O, Van Deerlin VM, Van Eldik LJ, Vardarajan BN, Vinters HV, Vonsattel JP, Weintraub S, Welsh-Bohmer KA, Williamson J, Wishnek S, Woltjer RL, Wright CB, Younkin SG, Yu CE, Yu L. PMID: 25199842.
      View in: PubMed   Mentions: 46     Fields:    Translation:Humans
    102. Longitudinal plasma amyloid beta in Alzheimer's disease clinical trials. Alzheimers Dement. 2015 Sep; 11(9):1069-79. Donohue MC, Moghadam SH, Roe AD, Sun CK, Edland SD, Thomas RG, Petersen RC, Sano M, Galasko D, Aisen PS, Rissman RA. PMID: 25301682.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    103. Influence of lifestyle modifications on age-related free radical injury to brain. JAMA Neurol. 2014 Sep; 71(9):1150-4. Peskind ER, Li G, Shofer JB, Millard SP, Leverenz JB, Yu CE, Raskind MA, Quinn JF, Galasko DR, Montine TJ. PMID: 25048271.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    104. Subjective cognitive complaints contribute to misdiagnosis of mild cognitive impairment. J Int Neuropsychol Soc. 2014 Sep; 20(8):836-47. Edmonds EC, Delano-Wood L, Galasko DR, Salmon DP, Bondi MW. PMID: 25156329.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    105. Aggregate effects of vascular risk factors on cerebrovascular changes in autopsy-confirmed Alzheimer's disease. Alzheimers Dement. 2015 Apr; 11(4):394-403.e1. Bangen KJ, Nation DA, Delano-Wood L, Weissberger GH, Hansen LA, Galasko DR, Salmon DP, Bondi MW. PMID: 25022538.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    106. Plasma exosomal a-synuclein is likely CNS-derived and increased in Parkinson's disease. Acta Neuropathol. 2014 Nov; 128(5):639-650. Shi M, Liu C, Cook TJ, Bullock KM, Zhao Y, Ginghina C, Li Y, Aro P, Dator R, He C, Hipp MJ, Zabetian CP, Peskind ER, Hu SC, Quinn JF, Galasko DR, Banks WA, Zhang J. PMID: 24997849.
      View in: PubMed   Mentions: 67     Fields:    Translation:HumansAnimalsCells
    107. Targeted discovery and validation of plasma biomarkers of Parkinson's disease. J Proteome Res. 2014 Nov 07; 13(11):4535-45. Pan C, Zhou Y, Dator R, Ginghina C, Zhao Y, Movius J, Peskind E, Zabetian CP, Quinn J, Galasko D, Stewart T, Shi M, Zhang J. PMID: 24853996.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    108. Cross-sectional and longitudinal relationships between cerebrospinal fluid biomarkers and cognitive function in people without cognitive impairment from across the adult life span. JAMA Neurol. 2014 Jun; 71(6):742-51. Li G, Millard SP, Peskind ER, Zhang J, Yu CE, Leverenz JB, Mayer C, Shofer JS, Raskind MA, Quinn JF, Galasko DR, Montine TJ. PMID: 24756381.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    109. Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria. Lancet Neurol. 2014 Jun; 13(6):614-29. Dubois B, Feldman HH, Jacova C, Hampel H, Molinuevo JL, Blennow K, DeKosky ST, Gauthier S, Selkoe D, Bateman R, Cappa S, Crutch S, Engelborghs S, Frisoni GB, Fox NC, Galasko D, Habert MO, Jicha GA, Nordberg A, Pasquier F, Rabinovici G, Robert P, Rowe C, Salloway S, Sarazin M, Epelbaum S, de Souza LC, Vellas B, Visser PJ, Schneider L, Stern Y, Scheltens P, Cummings JL. PMID: 24849862.
      View in: PubMed   Mentions: 482     Fields:    Translation:Humans
    110. Susceptibility of the conventional criteria for mild cognitive impairment to false-positive diagnostic errors. Alzheimers Dement. 2015 Apr; 11(4):415-24. Edmonds EC, Delano-Wood L, Clark LR, Jak AJ, Nation DA, McDonald CR, Libon DJ, Au R, Galasko D, Salmon DP, Bondi MW. PMID: 24857234.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    111. Alzheimer's Disease Cooperative Study Prevention Instrument Project assessing resource use and volunteer and paid work in healthy elders: a longitudinal study. J Am Geriatr Soc. 2014 May; 62(5):985-8. Zhu CW, Sano M, Ferris SH, Whitehouse PJ, Patterson MB, Galasko D, Schneider LS, Aisen PS. PMID: 24828933.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    112. PET imaging of amyloid with Florbetapir F 18 and PET imaging of dopamine degeneration with 18F-AV-133 (florbenazine) in patients with Alzheimer's disease and Lewy body disorders. BMC Neurol. 2014 Apr 09; 14:79. Siderowf A, Pontecorvo MJ, Shill HA, Mintun MA, Arora A, Joshi AD, Lu M, Adler CH, Galasko D, Liebsack C, Skovronsky DM, Sabbagh MN. PMID: 24716655.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    113. Clinical trial of an inhibitor of RAGE-Aß interactions in Alzheimer disease. Neurology. 2014 Apr 29; 82(17):1536-42. Galasko D, Bell J, Mancuso JY, Kupiec JW, Sabbagh MN, van Dyck C, Thomas RG, Aisen PS. PMID: 24696507.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansCTClinical Trials
    114. Effect of knowledge of APOE genotype on subjective and objective memory performance in healthy older adults. Am J Psychiatry. 2014 Feb; 171(2):201-8. Lineweaver TT, Bondi MW, Galasko D, Salmon DP. PMID: 24170170.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    115. TMEM106B is a genetic modifier of frontotemporal lobar degeneration with C9orf72 hexanucleotide repeat expansions. Acta Neuropathol. 2014 Mar; 127(3):407-18. Gallagher MD, Suh E, Grossman M, Elman L, McCluskey L, Van Swieten JC, Al-Sarraj S, Neumann M, Gelpi E, Ghetti B, Rohrer JD, Halliday G, Van Broeckhoven C, Seilhean D, Shaw PJ, Frosch MP, Alafuzoff I, Antonell A, Bogdanovic N, Brooks W, Cairns NJ, Cooper-Knock J, Cotman C, Cras P, Cruts M, De Deyn PP, DeCarli C, Dobson-Stone C, Engelborghs S, Fox N, Galasko D, Gearing M, Gijselinck I, Grafman J, Hartikainen P, Hatanpaa KJ, Highley JR, Hodges J, Hulette C, Ince PG, Jin LW, Kirby J, Kofler J, Kril J, Kwok JB, Levey A, Lieberman A, Llado A, Martin JJ, Masliah E, McDermott CJ, McKee A, McLean C, Mead S, Miller CA, Miller J, Munoz DG, Murrell J, Paulson H, Piguet O, Rossor M, Sanchez-Valle R, Sano M, Schneider J, Silbert LC, Spina S, van der Zee J, Van Langenhove T, Warren J, Wharton SB, White CL, Woltjer RL, Trojanowski JQ, Lee VM, Van Deerlin V, Chen-Plotkin AS. PMID: 24442578.
      View in: PubMed   Mentions: 44     Fields:    Translation:HumansCells
    116. Effect of TTP488 in patients with mild to moderate Alzheimer's disease. BMC Neurol. 2014 Jan 15; 14:12. Burstein AH, Grimes I, Galasko DR, Aisen PS, Sabbagh M, Mjalli AM. PMID: 24423155.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCTClinical Trials
    117. The new Qualitative Scoring MMSE Pentagon Test (QSPT) as a valid screening tool between autopsy-confirmed dementia with Lewy bodies and Alzheimer's disease. J Alzheimers Dis. 2014; 39(4):823-32. Mitolo M, Salmon DP, Gardini S, Galasko D, Grossi E, Caffarra P. PMID: 24284368.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansPHPublic Health
    118. Neuropsychological criteria for mild cognitive impairment improves diagnostic precision, biomarker associations, and progression rates. J Alzheimers Dis. 2014; 42(1):275-89. Bondi MW, Edmonds EC, Jak AJ, Clark LR, Delano-Wood L, McDonald CR, Nation DA, Libon DJ, Au R, Galasko D, Salmon DP. PMID: 24844687.
      View in: PubMed   Mentions: 62     Fields:    Translation:HumansCells
    119. Effects of baseline CSF a-synuclein on regional brain atrophy rates in healthy elders, mild cognitive impairment and Alzheimer's disease. PLoS One. 2013; 8(12):e85443. Mattsson N, Insel P, Tosun D, Zhang J, Jack CR, Galasko D, Weiner M. PMID: 24392009.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    120. Widespread microRNA dysregulation in multiple system atrophy - disease-related alteration in miR-96. Eur J Neurosci. 2014 Mar; 39(6):1026-41. Ubhi K, Rockenstein E, Kragh C, Inglis C, Spencer B, Michael S, Mante M, Adame A, Galasko D, Masliah E. PMID: 24304186.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansAnimalsCells
    121. Pulse pressure is associated with Alzheimer biomarkers in cognitively normal older adults. Neurology. 2013 Dec 03; 81(23):2024-7. Nation DA, Edland SD, Bondi MW, Salmon DP, Delano-Wood L, Peskind ER, Quinn JF, Galasko DR. PMID: 24225352.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    122. Abnormal P600 word repetition effect in elderly persons with preclinical Alzheimer's disease. Cogn Neurosci. 2013; 4(3-4):143-51. Olichney JM, Pak J, Salmon DP, Yang JC, Gahagan T, Nowacki R, Hansen L, Galasko D, Kutas M, Iragui-Madoz VJ. PMID: 24090465.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    123. Association of cerebrospinal fluid Aß42 with A2M gene in cognitively normal subjects. Neurobiol Aging. 2014 Feb; 35(2):357-64. Millard SP, Lutz F, Li G, Galasko DR, Farlow MR, Quinn JF, Kaye JA, Leverenz JB, Tsuang D, Yu CE, Peskind ER, Bekris LM. PMID: 24011543.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    124. Distinctive patterns of DNA methylation associated with Parkinson disease: identification of concordant epigenetic changes in brain and peripheral blood leukocytes. Epigenetics. 2013 Oct; 8(10):1030-8. Masliah E, Dumaop W, Galasko D, Desplats P. PMID: 23907097.
      View in: PubMed   Mentions: 60     Fields:    Translation:HumansCells
    125. Accounting for functional loss in Alzheimer's disease and dementia with Lewy bodies: beyond cognition. Alzheimers Dement. 2014 Mar; 10(2):171-8. Hamilton JM, Salmon DP, Raman R, Hansen LA, Masliah E, Peavy GM, Galasko D. PMID: 23850331.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    126. C9orf72 hexanucleotide repeat expansion and Guam amyotrophic lateral sclerosis-Parkinsonism-dementia complex. JAMA Neurol. 2013 Jun; 70(6):742-5. Dombroski BA, Galasko DR, Mata IF, Zabetian CP, Craig UK, Garruto RM, Oyanagi K, Schellenberg GD. PMID: 23588498.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    127. Progress in Alzheimer's disease research circa 2013: Is the glass half empty or half full? Alzheimers Res Ther. 2013; 5(3):26. Galasko D, Golde TE, Scheltens P. PMID: 23731836.
      View in: PubMed   Mentions: 1     Fields:    
    128. Interrater reliability of the new criteria for behavioral variant frontotemporal dementia. Neurology. 2013 May 21; 80(21):1973-7. Lamarre AK, Rascovsky K, Bostrom A, Toofanian P, Wilkins S, Sha SJ, Perry DC, Miller ZA, Naasan G, Laforce R, Hagen J, Takada LT, Tartaglia MC, Kang G, Galasko D, Salmon DP, Farias ST, Kaur B, Olichney JM, Quitania Park L, Mendez MF, Tsai PH, Teng E, Dickerson BC, Domoto-Reilly K, McGinnis S, Miller BL, Kramer JH. PMID: 23635967.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    129. Cerebrospinal fluid norepinephrine and cognition in subjects across the adult age span. Neurobiol Aging. 2013 Oct; 34(10):2287-92. Wang LY, Murphy RR, Hanscom B, Li G, Millard SP, Petrie EC, Galasko DR, Sikkema C, Raskind MA, Wilkinson CW, Peskind ER. PMID: 23639207.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    130. GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease. Neuron. 2013 Apr 24; 78(2):256-68. Cruchaga C, Kauwe JS, Harari O, Jin SC, Cai Y, Karch CM, Benitez BA, Jeng AT, Skorupa T, Carrell D, Bertelsen S, Bailey M, McKean D, Shulman JM, De Jager PL, Chibnik L, Bennett DA, Arnold SE, Harold D, Sims R, Gerrish A, Williams J, Van Deerlin VM, Lee VM, Shaw LM, Trojanowski JQ, Haines JL, Mayeux R, Pericak-Vance MA, Farrer LA, Schellenberg GD, Peskind ER, Galasko D, Fagan AM, Holtzman DM, Morris JC, Goate AM. PMID: 23562540.
      View in: PubMed   Mentions: 111     Fields:    Translation:HumansCells
    131. Improved statistical power of Alzheimer clinical trials by item-response theory: proof of concept by application to the activities of daily living scale. Alzheimer Dis Assoc Disord. 2013 Apr-Jun; 27(2):187-91. Ard MC, Galasko DR, Edland SD. PMID: 22874658.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    132. The diagnostic evaluation of a patient with dementia. Continuum (Minneap Minn). 2013 Apr; 19(2 Dementia):397-410. Galasko D. PMID: 23558485.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    133. Neuropsychiatric features of frontal lobe dysfunction in autopsy-confirmed patients with lewy bodies and "pure" Alzheimer disease. Am J Geriatr Psychiatry. 2013 Jun; 21(6):509-19. Peavy GM, Salmon DP, Edland SD, Tam S, Hansen LA, Masliah E, Galasko D, Hamilton JM. PMID: 23567425.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    134. Biomarkers for Alzheimer's disease in plasma, serum and blood - conceptual and practical problems. Alzheimers Res Ther. 2013; 5(2):10. Galasko D, Golde TE. PMID: 23470193.
      View in: PubMed   Mentions: 18     Fields:    
    135. Antioxidants for Alzheimer disease-reply. JAMA Neurol. 2013 Feb; 70(2):270-1. Galasko DR, Aisen P. PMID: 23400724.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    136. APOE e4 increases risk for dementia in pure synucleinopathies. JAMA Neurol. 2013 Feb; 70(2):223-8. Tsuang D, Leverenz JB, Lopez OL, Hamilton RL, Bennett DA, Schneider JA, Buchman AS, Larson EB, Crane PK, Kaye JA, Kramer P, Woltjer R, Trojanowski JQ, Weintraub D, Chen-Plotkin AS, Irwin DJ, Rick J, Schellenberg GD, Watson GS, Kukull W, Nelson PT, Jicha GA, Neltner JH, Galasko D, Masliah E, Quinn JF, Chung KA, Yearout D, Mata IF, Wan JY, Edwards KL, Montine TJ, Zabetian CP. PMID: 23407718.
      View in: PubMed   Mentions: 74     Fields:    Translation:HumansCells
    137. Temporal sequence learning in healthy aging and amnestic mild cognitive impairment. Exp Aging Res. 2013; 39(4):371-81. Pirogovsky E, Holden HM, Jenkins C, Peavy GM, Salmon DP, Galasko DR, Gilbert PE. PMID: 23875836.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    138. GBA mutations increase risk for Lewy body disease with and without Alzheimer disease pathology. Neurology. 2012 Nov 06; 79(19):1944-50. Tsuang D, Leverenz JB, Lopez OL, Hamilton RL, Bennett DA, Schneider JA, Buchman AS, Larson EB, Crane PK, Kaye JA, Kramer P, Woltjer R, Kukull W, Nelson PT, Jicha GA, Neltner JH, Galasko D, Masliah E, Trojanowski JQ, Schellenberg GD, Yearout D, Huston H, Fritts-Penniman A, Mata IF, Wan JY, Edwards KL, Montine TJ, Zabetian CP. PMID: 23035075.
      View in: PubMed   Mentions: 42     Fields:    Translation:Humans
    139. Potential use of ?-secretase modulators in the treatment of Alzheimer disease. Arch Neurol. 2012 Oct; 69(10):1255-8. Wagner SL, Tanzi RE, Mobley WC, Galasko D. PMID: 22801784.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimals
    140. Walking stabilizes cognitive functioning in Alzheimer's disease (AD) across one year. Arch Gerontol Geriatr. 2013 Jan-Feb; 56(1):96-103. Winchester J, Dick MB, Gillen D, Reed B, Miller B, Tinklenberg J, Mungas D, Chui H, Galasko D, Hewett L, Cotman CW. PMID: 22959822.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCTClinical Trials
    141. Early visuospatial deficits predict the occurrence of visual hallucinations in autopsy-confirmed dementia with Lewy bodies. Am J Geriatr Psychiatry. 2012 Sep; 20(9):773-81. Hamilton JM, Landy KM, Salmon DP, Hansen LA, Masliah E, Galasko D. PMID: 21997600.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    142. Tau phosphorylation pathway genes and cerebrospinal fluid tau levels in Alzheimer's disease. Am J Med Genet B Neuropsychiatr Genet. 2012 Oct; 159B(7):874-83. Bekris LM, Millard S, Lutz F, Li G, Galasko DR, Farlow MR, Quinn JF, Kaye JA, Leverenz JB, Tsuang DW, Yu CE, Peskind ER. PMID: 22927204.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    143. Higher education is not associated with greater cortical thickness in brain areas related to literacy or intelligence in normal aging or mild cognitive impairment. J Clin Exp Neuropsychol. 2012; 34(9):925-35. Pillai JA, McEvoy LK, Hagler DJ, Holland D, Dale AM, Salmon DP, Galasko D, Fennema-Notestine C. PMID: 22905705.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    144. Antioxidants for Alzheimer disease: a randomized clinical trial with cerebrospinal fluid biomarker measures. Arch Neurol. 2012 Jul; 69(7):836-41. Galasko DR, Peskind E, Clark CM, Quinn JF, Ringman JM, Jicha GA, Cotman C, Cottrell B, Montine TJ, Thomas RG, Aisen P. PMID: 22431837.
      View in: PubMed   Mentions: 80     Fields:    Translation:Humans
    145. The influence of chronic stress on dementia-related diagnostic change in older adults. Alzheimer Dis Assoc Disord. 2012 Jul-Sep; 26(3):260-6. Peavy GM, Jacobson MW, Salmon DP, Gamst AC, Patterson TL, Goldman S, Mills PJ, Khandrika S, Galasko D. PMID: 22037597.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    146. Novel late-onset Alzheimer disease loci variants associate with brain gene expression. Neurology. 2012 Jul 17; 79(3):221-8. Allen M, Zou F, Chai HS, Younkin CS, Crook J, Pankratz VS, Carrasquillo MM, Rowley CN, Nair AA, Middha S, Maharjan S, Nguyen T, Ma L, Malphrus KG, Palusak R, Lincoln S, Bisceglio G, Georgescu C, Schultz D, Rakhshan F, Kolbert CP, Jen J, Haines JL, Mayeux R, Pericak-Vance MA, Farrer LA, Schellenberg GD, Petersen RC, Graff-Radford NR, Dickson DW, Younkin SG, Ertekin-Taner N, Apostolova LG, Arnold SE, Baldwin CT, Barber R, Barmada MM, Beach T, Beecham GW, Beekly D, Bennett DA, Bigio EH, Bird TD, Blacker D, Boeve BF, Bowen JD, Boxer A, Burke JR, Buros J, Buxbaum JD, Cairns NJ, Cantwell LB, Cao C, Carlson CS, Carney RM, Carroll SL, Chui HC, Clark DG, Corneveaux J, Cotman CW, Crane PK, Cruchaga C, Cummings JL, De Jager PL, DeCarli C, DeKosky ST, Demirci FY, Diaz-Arrastia R, Dick M, Dombroski BA, Duara R, Ellis WD, Evans D, Faber KM, Fallon KB, Farlow MR, Ferris S, Foroud TM, Frosch M, Galasko DR, Gallins PJ, Ganguli M, Gearing M, Geschwind DH, Ghetti B, Gilbert JR, Gilman S, Giordani B, Glass JD, Goate AM, Green RC, Growdon JH, Hakonarson H, Hamilton RL, Hardy J, Harrell LE, Head E, Honig LS, Huentelman MJ, Hulette CM, Hyman BT, Jarvik GP, Jicha GA, Jin LW, Jun G, Kamboh MI, Karlawish J, Karydas A, Kauwe JS, Kaye JA, Kennedy N, Kim R, Koo EH, Kowall NW, Kramer P, Kukull WA, Lah JJ, Larson EB, Levey AI, Lieberman AP, Lopez OL, Lunetta KL, Mack WJ, Marson DC, Martin ER, Martiniuk F, Mash DC, Masliah E, McCormick WC, McCurry SM, McDavid AN, McKee AC, Mesulam M, Miller BL, Miller CA, Miller JW, Montine TJ, Morris JC, Myers AJ, Naj AC, Nowotny P, Parisi JE, Perl DP, Peskind E, Poon WW, Potter H, Quinn JF, Raj A, Rajbhandary RA, Raskind M, Reiman EM, Reisberg B, Reitz C, Ringman JM, Roberson ED, Rogaeva E, Rosenberg RN, Sano M, Saykin AJ, Schneider JA, Schneider LS, Seeley W, Shelanski ML, Slifer MA, Smith CD, Sonnen JA, Spina S, St George-Hyslop P, Stern RA, Tanzi RE, Trojanowski JQ, Troncoso JC, Tsuang DW, Van Deerlin VM, Vardarajan BN, Vinters HV, Vonsattel JP, Wang LS, Weintraub S, Welsh-Bohmer KA, Williamson J, Woltjer RL. PMID: 22722634.
      View in: PubMed   Mentions: 51     Fields:    Translation:Humans
    147. Recent Alzheimer's disease research highlights. Alzheimers Res Ther. 2012 May 18; 4(3):14. Galasko D, Golde T, Wilcock G. PMID: 22594696.
      View in: PubMed   Mentions:    Fields:    
    148. ADAM10 expression and promoter haplotype in Alzheimer's disease. Neurobiol Aging. 2012 Sep; 33(9):2229.e1-2229.e9. Bekris LM, Lutz F, Li G, Galasko DR, Farlow MR, Quinn JF, Kaye JA, Leverenz JB, Tsuang DW, Montine TJ, Peskind ER, Yu CE. PMID: 22572541.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    149. Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimer's diseases. Hum Mol Genet. 2012 Aug 01; 21(15):3500-12. Coppola G, Chinnathambi S, Lee JJ, Dombroski BA, Baker MC, Soto-Ortolaza AI, Lee SE, Klein E, Huang AY, Sears R, Lane JR, Karydas AM, Kenet RO, Biernat J, Wang LS, Cotman CW, Decarli CS, Levey AI, Ringman JM, Mendez MF, Chui HC, Le Ber I, Brice A, Lupton MK, Preza E, Lovestone S, Powell J, Graff-Radford N, Petersen RC, Boeve BF, Lippa CF, Bigio EH, Mackenzie I, Finger E, Kertesz A, Caselli RJ, Gearing M, Juncos JL, Ghetti B, Spina S, Bordelon YM, Tourtellotte WW, Frosch MP, Vonsattel JP, Zarow C, Beach TG, Albin RL, Lieberman AP, Lee VM, Trojanowski JQ, Van Deerlin VM, Bird TD, Galasko DR, Masliah E, White CL, Troncoso JC, Hannequin D, Boxer AL, Geschwind MD, Kumar S, Mandelkow EM, Wszolek ZK, Uitti RJ, Dickson DW, Haines JL, Mayeux R, Pericak-Vance MA, Farrer LA, Ross OA, Rademakers R, Schellenberg GD, Miller BL, Mandelkow E, Geschwind DH. PMID: 22556362.
      View in: PubMed   Mentions: 71     Fields:    Translation:Humans
    150. Incidence of new-onset seizures in mild to moderate Alzheimer disease. Arch Neurol. 2012 Mar; 69(3):368-72. Irizarry MC, Jin S, He F, Emond JA, Raman R, Thomas RG, Sano M, Quinn JF, Tariot PN, Galasko DR, Ishihara LS, Weil JG, Aisen PS. PMID: 22410444.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    151. Phosphorylated a-synuclein in Parkinson's disease. Sci Transl Med. 2012 Feb 15; 4(121):121ra20. Wang Y, Shi M, Chung KA, Zabetian CP, Leverenz JB, Berg D, Srulijes K, Trojanowski JQ, Lee VM, Siderowf AD, Hurtig H, Litvan I, Schiess MC, Peskind ER, Masuda M, Hasegawa M, Lin X, Pan C, Galasko D, Goldstein DS, Jensen PH, Yang H, Cain KC, Zhang J. PMID: 22344688.
      View in: PubMed   Mentions: 71     Fields:    Translation:HumansCells
    152. Antemortem pulse pressure elevation predicts cerebrovascular disease in autopsy-confirmed Alzheimer's disease. J Alzheimers Dis. 2012; 30(3):595-603. Nation DA, Delano-Wood L, Bangen KJ, Wierenga CE, Jak AJ, Hansen LA, Galasko DR, Salmon DP, Bondi MW. PMID: 22451309.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    153. Detection of peri-synaptic amyloid-ß pyroglutamate aggregates in early stages of Alzheimer's disease and in AßPP transgenic mice using a novel monoclonal antibody. J Alzheimers Dis. 2012; 28(4):783-94. Mandler M, Rockenstein E, Ubhi K, Hansen L, Adame A, Michael S, Galasko D, Santic R, Mattner F, Masliah E. PMID: 22064070.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimalsCells
    154. Fractional synthesis and clearance rates for amyloid ß. Nat Med. 2011 Oct 11; 17(10):1178-9; author reply 1179-80. Edland SD, Galasko DR. PMID: 21988985.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    155. Degree of bilingualism predicts age of diagnosis of Alzheimer's disease in low-education but not in highly educated Hispanics. Neuropsychologia. 2011 Dec; 49(14):3826-30. Gollan TH, Salmon DP, Montoya RI, Galasko DR. PMID: 22001315.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    156. The ageing systemic milieu negatively regulates neurogenesis and cognitive function. Nature. 2011 Aug 31; 477(7362):90-4. Villeda SA, Luo J, Mosher KI, Zou B, Britschgi M, Bieri G, Stan TM, Fainberg N, Ding Z, Eggel A, Lucin KM, Czirr E, Park JS, Couillard-Després S, Aigner L, Li G, Peskind ER, Kaye JA, Quinn JF, Galasko DR, Xie XS, Rando TA, Wyss-Coray T. PMID: 21886162.
      View in: PubMed   Mentions: 420     Fields:    Translation:Animals
    157. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain. 2011 Sep; 134(Pt 9):2456-77. Rascovsky K, Hodges JR, Knopman D, Mendez MF, Kramer JH, Neuhaus J, van Swieten JC, Seelaar H, Dopper EG, Onyike CU, Hillis AE, Josephs KA, Boeve BF, Kertesz A, Seeley WW, Rankin KP, Johnson JK, Gorno-Tempini ML, Rosen H, Prioleau-Latham CE, Lee A, Kipps CM, Lillo P, Piguet O, Rohrer JD, Rossor MN, Warren JD, Fox NC, Galasko D, Salmon DP, Black SE, Mesulam M, Weintraub S, Dickerson BC, Diehl-Schmid J, Pasquier F, Deramecourt V, Lebert F, Pijnenburg Y, Chow TW, Manes F, Grafman J, Cappa SF, Freedman M, Grossman M, Miller BL. PMID: 21810890.
      View in: PubMed   Mentions: 766     Fields:    Translation:Humans
    158. A randomized, double-blind, placebo-controlled trial of simvastatin to treat Alzheimer disease. Neurology. 2011 Aug 09; 77(6):556-63. Sano M, Bell KL, Galasko D, Galvin JE, Thomas RG, van Dyck CH, Aisen PS. PMID: 21795660.
      View in: PubMed   Mentions: 73     Fields:    Translation:Humans
    159. Modeling of pathological traits in Alzheimer's disease based on systemic extracellular signaling proteome. Mol Cell Proteomics. 2011 Oct; 10(10):M111.008862. Britschgi M, Rufibach K, Huang SL, Clark CM, Kaye JA, Li G, Peskind ER, Quinn JF, Galasko DR, Wyss-Coray T. PMID: 21742799.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    160. PF-04494700, an oral inhibitor of receptor for advanced glycation end products (RAGE), in Alzheimer disease. Alzheimer Dis Assoc Disord. 2011 Jul-Sep; 25(3):206-12. Sabbagh MN, Agro A, Bell J, Aisen PS, Schweizer E, Galasko D. PMID: 21192237.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    161. The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers. Alzheimers Dement. 2011 Jul; 7(4):386-395.e6. Mattsson N, Andreasson U, Persson S, Arai H, Batish SD, Bernardini S, Bocchio-Chiavetto L, Blankenstein MA, Carrillo MC, Chalbot S, Coart E, Chiasserini D, Cutler N, Dahlfors G, Duller S, Fagan AM, Forlenza O, Frisoni GB, Galasko D, Galimberti D, Hampel H, Handberg A, Heneka MT, Herskovits AZ, Herukka SK, Holtzman DM, Humpel C, Hyman BT, Iqbal K, Jucker M, Kaeser SA, Kaiser E, Kapaki E, Kidd D, Klivenyi P, Knudsen CS, Kummer MP, Lui J, Lladó A, Lewczuk P, Li QX, Martins R, Masters C, McAuliffe J, Mercken M, Moghekar A, Molinuevo JL, Montine TJ, Nowatzke W, O'Brien R, Otto M, Paraskevas GP, Parnetti L, Petersen RC, Prvulovic D, de Reus HP, Rissman RA, Scarpini E, Stefani A, Soininen H, Schröder J, Shaw LM, Skinningsrud A, Skrogstad B, Spreer A, Talib L, Teunissen C, Trojanowski JQ, Tumani H, Umek RM, Van Broeck B, Vanderstichele H, Vecsei L, Verbeek MM, Windisch M, Zhang J, Zetterberg H, Blennow K. PMID: 21784349.
      View in: PubMed   Mentions: 101     Fields:    Translation:HumansCells
    162. Right sizing funding for Alzheimer's disease. Alzheimers Res Ther. 2011 May 06; 3(3):17. Golde TE, Lamb BT, Galasko D. PMID: 21554753.
      View in: PubMed   Mentions:    Fields:    
    163. Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet. 2011 May; 43(5):436-41. Naj AC, Jun G, Beecham GW, Wang LS, Vardarajan BN, Buros J, Gallins PJ, Buxbaum JD, Jarvik GP, Crane PK, Larson EB, Bird TD, Boeve BF, Graff-Radford NR, De Jager PL, Evans D, Schneider JA, Carrasquillo MM, Ertekin-Taner N, Younkin SG, Cruchaga C, Kauwe JS, Nowotny P, Kramer P, Hardy J, Huentelman MJ, Myers AJ, Barmada MM, Demirci FY, Baldwin CT, Green RC, Rogaeva E, St George-Hyslop P, Arnold SE, Barber R, Beach T, Bigio EH, Bowen JD, Boxer A, Burke JR, Cairns NJ, Carlson CS, Carney RM, Carroll SL, Chui HC, Clark DG, Corneveaux J, Cotman CW, Cummings JL, DeCarli C, DeKosky ST, Diaz-Arrastia R, Dick M, Dickson DW, Ellis WG, Faber KM, Fallon KB, Farlow MR, Ferris S, Frosch MP, Galasko DR, Ganguli M, Gearing M, Geschwind DH, Ghetti B, Gilbert JR, Gilman S, Giordani B, Glass JD, Growdon JH, Hamilton RL, Harrell LE, Head E, Honig LS, Hulette CM, Hyman BT, Jicha GA, Jin LW, Johnson N, Karlawish J, Karydas A, Kaye JA, Kim R, Koo EH, Kowall NW, Lah JJ, Levey AI, Lieberman AP, Lopez OL, Mack WJ, Marson DC, Martiniuk F, Mash DC, Masliah E, McCormick WC, McCurry SM, McDavid AN, McKee AC, Mesulam M, Miller BL, Miller CA, Miller JW, Parisi JE, Perl DP, Peskind E, Petersen RC, Poon WW, Quinn JF, Rajbhandary RA, Raskind M, Reisberg B, Ringman JM, Roberson ED, Rosenberg RN, Sano M, Schneider LS, Seeley W, Shelanski ML, Slifer MA, Smith CD, Sonnen JA, Spina S, Stern RA, Tanzi RE, Trojanowski JQ, Troncoso JC, Van Deerlin VM, Vinters HV, Vonsattel JP, Weintraub S, Welsh-Bohmer KA, Williamson J, Woltjer RL, Cantwell LB, Dombroski BA, Beekly D, Lunetta KL, Martin ER, Kamboh MI, Saykin AJ, Reiman EM, Bennett DA, Morris JC, Montine TJ, Goate AM, Blacker D, Tsuang DW, Hakonarson H, Kukull WA, Foroud TM, Haines JL, Mayeux R, Pericak-Vance MA, Farrer LA, Schellenberg GD. PMID: 21460841.
      View in: PubMed   Mentions: 672     Fields:    Translation:Humans
    164. Complement 3 and factor h in human cerebrospinal fluid in Parkinson's disease, Alzheimer's disease, and multiple-system atrophy. Am J Pathol. 2011 Apr; 178(4):1509-16. Wang Y, Hancock AM, Bradner J, Chung KA, Quinn JF, Peskind ER, Galasko D, Jankovic J, Zabetian CP, Kim HM, Leverenz JB, Montine TJ, Ginghina C, Edwards KL, Snapinn KW, Goldstein DS, Shi M, Zhang J. PMID: 21435440.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    165. Comparison of the memory performance index with standard neuropsychological measures of cognition. Am J Alzheimers Dis Other Demen. 2011 05; 26(3):235-9. Rafii MS, Taylor C, Coutinho A, Kim K, Galasko D. PMID: 21406427.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansPHPublic Health
    166. Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression. Ann Neurol. 2011 Mar; 69(3):570-80. Shi M, Bradner J, Hancock AM, Chung KA, Quinn JF, Peskind ER, Galasko D, Jankovic J, Zabetian CP, Kim HM, Leverenz JB, Montine TJ, Ginghina C, Kang UJ, Cain KC, Wang Y, Aasly J, Goldstein D, Zhang J. PMID: 21400565.
      View in: PubMed   Mentions: 135     Fields:    Translation:HumansCells
    167. Global clinical dementia rating of 0.5 in MCI masks variability related to level of function. Neurology. 2011 Feb 15; 76(7):652-9. Chang YL, Bondi MW, McEvoy LK, Fennema-Notestine C, Salmon DP, Galasko D, Hagler DJ, Dale AM. PMID: 21321338.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    168. Identification and validation of novel cerebrospinal fluid biomarkers for staging early Alzheimer's disease. PLoS One. 2011 Jan 12; 6(1):e16032. Perrin RJ, Craig-Schapiro R, Malone JP, Shah AR, Gilmore P, Davis AE, Roe CM, Peskind ER, Li G, Galasko DR, Clark CM, Quinn JF, Kaye JA, Morris JC, Holtzman DM, Townsend RR, Fagan AM. PMID: 21264269.
      View in: PubMed   Mentions: 57     Fields:    Translation:Humans
    169. Amyloid precursor protein (APP) processing genes and cerebrospinal fluid APP cleavage product levels in Alzheimer's disease. Neurobiol Aging. 2011 Mar; 32(3):556.e13-23. Bekris LM, Galloway NM, Millard S, Lockhart D, Li G, Galasko DR, Farlow MR, Clark CM, Quinn JF, Kaye JA, Schellenberg GD, Leverenz JB, Seubert P, Tsuang DW, Peskind ER, Yu CE. PMID: 21196064.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    170. CSF Aß(42) and tau in Parkinson's disease with cognitive impairment. Mov Disord. 2010 Nov 15; 25(15):2682-5. Montine TJ, Shi M, Quinn JF, Peskind ER, Craft S, Ginghina C, Chung KA, Kim H, Galasko DR, Jankovic J, Zabetian CP, Leverenz JB, Zhang J. PMID: 20818673.
      View in: PubMed   Mentions: 65     Fields:    Translation:Humans
    171. YKL-40: a novel prognostic fluid biomarker for preclinical Alzheimer's disease. Biol Psychiatry. 2010 Nov 15; 68(10):903-12. Craig-Schapiro R, Perrin RJ, Roe CM, Xiong C, Carter D, Cairns NJ, Mintun MA, Peskind ER, Li G, Galasko DR, Clark CM, Quinn JF, D'Angelo G, Malone JP, Townsend RR, Morris JC, Fagan AM, Holtzman DM. PMID: 21035623.
      View in: PubMed   Mentions: 116     Fields:    Translation:HumansCells
    172. High normal fasting blood glucose is associated with dementia in Chinese elderly. Alzheimers Dement. 2010 Nov; 6(6):440-7. Mortimer JA, Borenstein AR, Ding D, Decarli C, Zhao Q, Copenhaver C, Guo Q, Chu S, Galasko D, Salmon DP, Dai Q, Wu Y, Petersen R, Hong Z. PMID: 21044774.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    173. SNCA variant associated with Parkinson disease and plasma alpha-synuclein level. Arch Neurol. 2010 Nov; 67(11):1350-6. Mata IF, Shi M, Agarwal P, Chung KA, Edwards KL, Factor SA, Galasko DR, Ginghina C, Griffith A, Higgins DS, Kay DM, Kim H, Leverenz JB, Quinn JF, Roberts JW, Samii A, Snapinn KW, Tsuang DW, Yearout D, Zhang J, Payami H, Zabetian CP. PMID: 21060011.
      View in: PubMed   Mentions: 51     Fields:    Translation:HumansCells
    174. Revising the definition of Alzheimer's disease: a new lexicon. Lancet Neurol. 2010 Nov; 9(11):1118-27. Dubois B, Feldman HH, Jacova C, Cummings JL, Dekosky ST, Barberger-Gateau P, Delacourte A, Frisoni G, Fox NC, Galasko D, Gauthier S, Hampel H, Jicha GA, Meguro K, O'Brien J, Pasquier F, Robert P, Rossor M, Salloway S, Sarazin M, de Souza LC, Stern Y, Visser PJ, Scheltens P. PMID: 20934914.
      View in: PubMed   Mentions: 427     Fields:    Translation:Humans
    175. Brain structure and cerebrovascular risk in cognitively impaired patients: Shanghai Community Brain Health Initiative-pilot phase. Arch Neurol. 2010 Oct; 67(10):1231-7. He J, Iosif AM, Lee DY, Martinez O, Chu S, Carmichael O, Mortimer JA, Zhao Q, Ding D, Guo Q, Galasko D, Salmon DP, Dai Q, Wu Y, Petersen RC, Hong Z, Borenstein AR, DeCarli C. PMID: 20937951.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    176. Functional evaluation distinguishes MCI patients from healthy elderly people--the ADCS/MCI/ADL scale. J Nutr Health Aging. 2010 Oct; 14(8):703-9. Pedrosa H, De Sa A, Guerreiro M, Maroco J, Simoes MR, Galasko D, de Mendonca A. PMID: 20922349.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    177. Neuropathology of dementia with Lewy bodies in advanced age: a comparison with Alzheimer disease. Neurosci Lett. 2010 Nov 26; 485(3):222-7. Ubhi K, Peng K, Lessig S, Estrella J, Adame A, Galasko D, Salmon DP, Hansen LA, Kawas CH, Masliah E. PMID: 20849919.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    178. SNPs associated with cerebrospinal fluid phospho-tau levels influence rate of decline in Alzheimer's disease. PLoS Genet. 2010 Sep 16; 6(9):e1001101. Cruchaga C, Kauwe JS, Mayo K, Spiegel N, Bertelsen S, Nowotny P, Shah AR, Abraham R, Hollingworth P, Harold D, Owen MM, Williams J, Lovestone S, Peskind ER, Li G, Leverenz JB, Galasko D, Morris JC, Fagan AM, Holtzman DM, Goate AM. PMID: 20862329.
      View in: PubMed   Mentions: 56     Fields:    Translation:Humans
    179. Reduced hypocretin (orexin) levels in dementia with Lewy bodies. Neuroreport. 2010 Aug 04; 21(11):756-60. Lessig S, Ubhi K, Galasko D, Adame A, Pham E, Remidios K, Chang M, Hansen LA, Masliah E. PMID: 20531237.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    180. Increased cerebrospinal fluid F2-isoprostanes are associated with aging and latent Alzheimer's disease as identified by biomarkers. Neuromolecular Med. 2011 Mar; 13(1):37-43. Montine TJ, Peskind ER, Quinn JF, Wilson AM, Montine KS, Galasko D. PMID: 20632131.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    181. Progressive accumulation of amyloid-beta oligomers in Alzheimer's disease and in amyloid precursor protein transgenic mice is accompanied by selective alterations in synaptic scaffold proteins. FEBS J. 2010 Jul; 277(14):3051-67. Pham E, Crews L, Ubhi K, Hansen L, Adame A, Cartier A, Salmon D, Galasko D, Michael S, Savas JN, Yates JR, Glabe C, Masliah E. PMID: 20573181.
      View in: PubMed   Mentions: 72     Fields:    Translation:HumansAnimalsCells
    182. Significance and confounders of peripheral DJ-1 and alpha-synuclein in Parkinson's disease. Neurosci Lett. 2010 Aug 09; 480(1):78-82. Shi M, Zabetian CP, Hancock AM, Ginghina C, Hong Z, Yearout D, Chung KA, Quinn JF, Peskind ER, Galasko D, Jankovic J, Leverenz JB, Zhang J. PMID: 20540987.
      View in: PubMed   Mentions: 48     Fields:    Translation:HumansCells
    183. Alzheimer disease pathology in cognitively healthy elderly: a genome-wide study. Neurobiol Aging. 2011 Dec; 32(12):2113-22. Kramer PL, Xu H, Woltjer RL, Westaway SK, Clark D, Erten-Lyons D, Kaye JA, Welsh-Bohmer KA, Troncoso JC, Markesbery WR, Petersen RC, Turner RS, Kukull WA, Bennett DA, Galasko D, Morris JC, Ott J. PMID: 20452100.
      View in: PubMed   Mentions: 43     Fields:    Translation:HumansCells
    184. Selective molecular alterations in the autophagy pathway in patients with Lewy body disease and in models of alpha-synucleinopathy. PLoS One. 2010 Feb 19; 5(2):e9313. Crews L, Spencer B, Desplats P, Patrick C, Paulino A, Rockenstein E, Hansen L, Adame A, Galasko D, Masliah E. PMID: 20174468.
      View in: PubMed   Mentions: 109     Fields:    Translation:HumansAnimalsCells
    185. DJ-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease. Brain. 2010 Mar; 133(Pt 3):713-26. Hong Z, Shi M, Chung KA, Quinn JF, Peskind ER, Galasko D, Jankovic J, Zabetian CP, Leverenz JB, Baird G, Montine TJ, Hancock AM, Hwang H, Pan C, Bradner J, Kang UJ, Jensen PH, Zhang J. PMID: 20157014.
      View in: PubMed   Mentions: 180     Fields:    Translation:Humans
    186. Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions. Nat Genet. 2010 Mar; 42(3):234-9. Van Deerlin VM, Sleiman PM, Martinez-Lage M, Chen-Plotkin A, Wang LS, Graff-Radford NR, Dickson DW, Rademakers R, Boeve BF, Grossman M, Arnold SE, Mann DM, Pickering-Brown SM, Seelaar H, Heutink P, van Swieten JC, Murrell JR, Ghetti B, Spina S, Grafman J, Hodges J, Spillantini MG, Gilman S, Lieberman AP, Kaye JA, Woltjer RL, Bigio EH, Mesulam M, Al-Sarraj S, Troakes C, Rosenberg RN, White CL, Ferrer I, Lladó A, Neumann M, Kretzschmar HA, Hulette CM, Welsh-Bohmer KA, Miller BL, Alzualde A, Lopez de Munain A, McKee AC, Gearing M, Levey AI, Lah JJ, Hardy J, Rohrer JD, Lashley T, Mackenzie IR, Feldman HH, Hamilton RL, Dekosky ST, van der Zee J, Kumar-Singh S, Van Broeckhoven C, Mayeux R, Vonsattel JP, Troncoso JC, Kril JJ, Kwok JB, Halliday GM, Bird TD, Ince PG, Shaw PJ, Cairns NJ, Morris JC, McLean CA, DeCarli C, Ellis WG, Freeman SH, Frosch MP, Growdon JH, Perl DP, Sano M, Bennett DA, Schneider JA, Beach TG, Reiman EM, Woodruff BK, Cummings J, Vinters HV, Miller CA, Chui HC, Alafuzoff I, Hartikainen P, Seilhean D, Galasko D, Masliah E, Cotman CW, Tuñón MT, Martínez MC, Munoz DG, Carroll SL, Marson D, Riederer PF, Bogdanovic N, Schellenberg GD, Hakonarson H, Trojanowski JQ, Lee VM. PMID: 20154673.
      View in: PubMed   Mentions: 167     Fields:    Translation:HumansCells
    187. Effects of apolipoprotein E-epsilon4 and -epsilon2 in amnestic mild cognitive impairment and dementia in Shanghai: SCOBHI-P. Am J Alzheimers Dis Other Demen. 2010 May; 25(3):233-8. Borenstein AR, Mortimer JA, Schellenberg GD, DeCarli C, Copenhaver C, Galasko D, Salmon DP, Petersen R. PMID: 20142627.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    188. Biomarkers of oxidative damage and inflammation in Alzheimer's disease. Biomark Med. 2010 Feb; 4(1):27-36. Galasko D, Montine TJ. PMID: 20383271.
      View in: PubMed   Mentions: 45     Fields:    Translation:Humans
    189. The spectrum of mutations in progranulin: a collaborative study screening 545 cases of neurodegeneration. Arch Neurol. 2010 Feb; 67(2):161-70. Yu CE, Bird TD, Bekris LM, Montine TJ, Leverenz JB, Steinbart E, Galloway NM, Feldman H, Woltjer R, Miller CA, Wood EM, Grossman M, McCluskey L, Clark CM, Neumann M, Danek A, Galasko DR, Arnold SE, Chen-Plotkin A, Karydas A, Miller BL, Trojanowski JQ, Lee VM, Schellenberg GD, Van Deerlin VM. PMID: 20142524.
      View in: PubMed   Mentions: 58     Fields:    Translation:HumansCells
    190. Distinct cerebrospinal fluid amyloid beta peptide signatures in sporadic and PSEN1 A431E-associated familial Alzheimer's disease. Mol Neurodegener. 2010 Jan 14; 5:2. Portelius E, Andreasson U, Ringman JM, Buerger K, Daborg J, Buchhave P, Hansson O, Harmsen A, Gustavsson MK, Hanse E, Galasko D, Hampel H, Blennow K, Zetterberg H. PMID: 20145736.
      View in: PubMed   Mentions: 27     Fields:    
    191. Effects of chronic stress on memory decline in cognitively normal and mildly impaired older adults. Am J Psychiatry. 2009 Dec; 166(12):1384-91. Peavy GM, Salmon DP, Jacobson MW, Hervey A, Gamst AC, Wolfson T, Patterson TL, Goldman S, Mills PJ, Khandrika S, Galasko D. PMID: 19755573.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    192. Parkinson-dementia complex and development of a new stable isotope dilution assay for BMAA detection in tissue. Toxicol Appl Pharmacol. 2009 Oct 15; 240(2):180-8. Snyder LR, Cruz-Aguado R, Sadilek M, Galasko D, Shaw CA, Montine TJ. PMID: 19716838.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimals
    193. Welcome to Alzheimer's research & therapy. Alzheimers Res Ther. 2009 Jul 09; 1(1):1. Donnelly A, Galasko D, Golde T, Mulvany F, Wilcock G. PMID: 19671199.
      View in: PubMed   Mentions:    Fields:    
    194. Neuroprotective natural antibodies to assemblies of amyloidogenic peptides decrease with normal aging and advancing Alzheimer's disease. Proc Natl Acad Sci U S A. 2009 Jul 21; 106(29):12145-50. Britschgi M, Olin CE, Johns HT, Takeda-Uchimura Y, LeMieux MC, Rufibach K, Rajadas J, Zhang H, Tomooka B, Robinson WH, Clark CM, Fagan AM, Galasko DR, Holtzman DM, Jutel M, Kaye JA, Lemere CA, Leszek J, Li G, Peskind ER, Quinn JF, Yesavage JA, Ghiso JA, Wyss-Coray T. PMID: 19581601.
      View in: PubMed   Mentions: 51     Fields:    Translation:AnimalsCellsPHPublic Health
    195. Identification of novel susceptibility loci for Guam neurodegenerative disease: challenges of genome scans in genetic isolates. Hum Mol Genet. 2009 Oct 01; 18(19):3725-38. Sieh W, Choi Y, Chapman NH, Craig UK, Steinbart EJ, Rothstein JH, Oyanagi K, Garruto RM, Bird TD, Galasko DR, Schellenberg GD, Wijsman EM. PMID: 19567404.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    196. Cerebrospinal fluid concentration of brain-derived neurotrophic factor and cognitive function in non-demented subjects. PLoS One. 2009; 4(5):e5424. Li G, Peskind ER, Millard SP, Chi P, Sokal I, Yu CE, Bekris LM, Raskind MA, Galasko DR, Montine TJ. PMID: 19412541.
      View in: PubMed   Mentions: 45     Fields:    Translation:Humans
    197. Preclinical evidence of Alzheimer changes: convergent cerebrospinal fluid biomarker and fluorodeoxyglucose positron emission tomography findings. Arch Neurol. 2009 May; 66(5):632-7. Petrie EC, Cross DJ, Galasko D, Schellenberg GD, Raskind MA, Peskind ER, Minoshima S. PMID: 19433663.
      View in: PubMed   Mentions: 43     Fields:    Translation:HumansCells
    198. Lack of cerebral bmaa in human cerebral cortex. Neurology. 2009 Apr 14; 72(15):1360-1. Snyder LR, Cruz-Aguado R, Sadilek M, Galasko D, Shaw CA, Montine TJ. PMID: 19365059.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansPHPublic Health
    199. A worldwide multicentre comparison of assays for cerebrospinal fluid biomarkers in Alzheimer's disease. Ann Clin Biochem. 2009 May; 46(Pt 3):235-40. Verwey NA, van der Flier WM, Blennow K, Clark C, Sokolow S, De Deyn PP, Galasko D, Hampel H, Hartmann T, Kapaki E, Lannfelt L, Mehta PD, Parnetti L, Petzold A, Pirttila T, Saleh L, Skinningsrud A, Swieten JC, Verbeek MM, Wiltfang J, Younkin S, Scheltens P, Blankenstein MA. PMID: 19342441.
      View in: PubMed   Mentions: 46     Fields:    Translation:Humans
    200. The Alzheimer's Disease Centers' Uniform Data Set (UDS): the neuropsychologic test battery. Alzheimer Dis Assoc Disord. 2009 Apr-Jun; 23(2):91-101. Weintraub S, Salmon D, Mercaldo N, Ferris S, Graff-Radford NR, Chui H, Cummings J, DeCarli C, Foster NL, Galasko D, Peskind E, Dietrich W, Beekly DL, Kukull WA, Morris JC. PMID: 19474567.
      View in: PubMed   Mentions: 248     Fields:    Translation:Humans
    201. Reduction of SorLA/LR11, a sorting protein limiting beta-amyloid production, in Alzheimer disease cerebrospinal fluid. Arch Neurol. 2009 Apr; 66(4):448-57. Ma QL, Galasko DR, Ringman JM, Vinters HV, Edland SD, Pomakian J, Ubeda OJ, Rosario ER, Teter B, Frautschy SA, Cole GM. PMID: 19364929.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansCells
    202. Verbal learning and memory in patients with dementia with Lewy bodies or Parkinson's disease with dementia. J Clin Exp Neuropsychol. 2009 Oct; 31(7):823-34. Filoteo JV, Salmon DP, Schiehser DM, Kane AE, Hamilton JM, Rilling LM, Lucas JA, Zizak V, Galasko DR. PMID: 19221922.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    203. The ALS/PDC syndrome of Guam and the cycad hypothesis. Neurology. 2009 Feb 03; 72(5):473, 476; author reply 475-6. Borenstein AR, Mortimer JA, Schellenberg GD, Galasko D, McGeer PL, Steele JC. PMID: 19188582.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    204. Apolipoprotein E highly correlates with AbetaPP- and tau-related markers in human cerebrospinal fluid. J Alzheimers Dis. 2008 Nov; 15(3):409-17. Vuletic S, Li G, Peskind ER, Kennedy H, Marcovina SM, Leverenz JB, Petrie EC, Lee VM, Galasko D, Schellenberg GD, Albers JJ. PMID: 18997294.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    205. Visuospatial deficits predict rate of cognitive decline in autopsy-verified dementia with Lewy bodies. Neuropsychology. 2008 Nov; 22(6):729-37. Hamilton JM, Salmon DP, Galasko D, Raman R, Emond J, Hansen LA, Masliah E, Thal LJ. PMID: 18999346.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCells
    206. Guest authorship, mortality reporting, and integrity in rofecoxib studies. JAMA. 2008 Aug 27; 300(8):901-2; author reply 904-6. Ferris S, Galasko D, Kirby L. PMID: 18728256.
      View in: PubMed   Mentions: 1     Fields:    
    207. Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors. Lancet Neurol. 2008 Sep; 7(9):812-26. Kalaria RN, Maestre GE, Arizaga R, Friedland RP, Galasko D, Hall K, Luchsinger JA, Ogunniyi A, Perry EK, Potocnik F, Prince M, Stewart R, Wimo A, Zhang ZX, Antuono P. PMID: 18667359.
      View in: PubMed   Mentions: 207     Fields:    Translation:Humans
    208. Diagnosing depression in Alzheimer disease with the national institute of mental health provisional criteria. Am J Geriatr Psychiatry. 2008 Jun; 16(6):469-77. Teng E, Ringman JM, Ross LK, Mulnard RA, Dick MB, Bartzokis G, Davies HD, Galasko D, Hewett L, Mungas D, Reed BR, Schneider LS, Segal-Gidan F, Yaffe K, Cummings JL. PMID: 18515691.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    209. A roadmap for the prevention of dementia: the inaugural Leon Thal Symposium. Alzheimers Dement. 2008 May; 4(3):156-63. Khachaturian ZS, Petersen RC, Gauthier S, Buckholtz N, Corey-Bloom JP, Evans B, Fillit H, Foster N, Greenberg B, Grundman M, Sano M, Simpkins J, Schneider LS, Weiner MW, Galasko D, Hyman B, Kuller L, Schenk D, Snyder S, Thomas RG, Tuszynski MH, Vellas B, Wurtman RJ, Snyder PJ, Frank RA, Albert M, Doody R, Ferris S, Kaye J, Koo E, Morrison-Bogorad M, Reisberg B, Salmon DP, Gilman S, Mohs R, Aisen PS, Breitner JC, Cummings JL, Kawas C, Phelps C, Poirier J, Sabbagh M, Touchon J, Khachaturian AS, Bain LJ. PMID: 18631960.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    210. Distinct cognitive profiles and rates of decline on the Mattis Dementia Rating Scale in autopsy-confirmed frontotemporal dementia and Alzheimer's disease. J Int Neuropsychol Soc. 2008 May; 14(3):373-83. Rascovsky K, Salmon DP, Hansen LA, Galasko D. PMID: 18419836.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    211. TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysis. Lancet Neurol. 2008 May; 7(5):409-16. Van Deerlin VM, Leverenz JB, Bekris LM, Bird TD, Yuan W, Elman LB, Clay D, Wood EM, Chen-Plotkin AS, Martinez-Lage M, Steinbart E, McCluskey L, Grossman M, Neumann M, Wu IL, Yang WS, Kalb R, Galasko DR, Montine TJ, Trojanowski JQ, Lee VM, Schellenberg GD, Yu CE. PMID: 18396105.
      View in: PubMed   Mentions: 236     Fields:    Translation:Humans
    212. Multiple SNPs within and surrounding the apolipoprotein E gene influence cerebrospinal fluid apolipoprotein E protein levels. J Alzheimers Dis. 2008 Apr; 13(3):255-66. Bekris LM, Millard SP, Galloway NM, Vuletic S, Albers JJ, Li G, Galasko DR, DeCarli C, Farlow MR, Clark CM, Quinn JF, Kaye JA, Schellenberg GD, Tsuang D, Peskind ER, Yu CE. PMID: 18430993.
      View in: PubMed   Mentions: 40     Fields:    Translation:HumansCells
    213. Primary care screening for dementia and mild cognitive impairment. JAMA. 2008 Mar 12; 299(10):1132; author reply 1133-4. Rafii MS, Galasko D. PMID: 18334686.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    214. Empiric refinement of the pathologic assessment of Lewy-related pathology in the dementia patient. Brain Pathol. 2008 Apr; 18(2):220-4. Leverenz JB, Hamilton R, Tsuang DW, Schantz A, Vavrek D, Larson EB, Kukull WA, Lopez O, Galasko D, Masliah E, Kaye J, Woltjer R, Clark C, Trojanowski JQ, Montine TJ. PMID: 18241240.
      View in: PubMed   Mentions: 43     Fields:    Translation:HumansCells
    215. Application of targeted quantitative proteomics analysis in human cerebrospinal fluid using a liquid chromatography matrix-assisted laser desorption/ionization time-of-flight tandem mass spectrometer (LC MALDI TOF/TOF) platform. J Proteome Res. 2008 Feb; 7(2):720-30. Pan S, Rush J, Peskind ER, Galasko D, Chung K, Quinn J, Jankovic J, Leverenz JB, Zabetian C, Pan C, Wang Y, Oh JH, Gao J, Zhang J, Montine T, Zhang J. PMID: 18186601.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCells
    216. The memory disorders clinic. Handb Clin Neurol. 2008; 89:107-12. Galasko D. PMID: 18631736.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    217. [ALS, Parkinson-Dementia complex and late-life dementia in the Chamorros Guam--an update]. Rinsho Shinkeigaku. 2007 Nov; 47(11):961. Galasko D. PMID: 18210848.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    218. Progressive impairment on neuropsychological tasks in a longitudinal study of preclinical Alzheimer's disease. Neuropsychology. 2007 Nov; 21(6):696-705. Mickes L, Wixted JT, Fennema-Notestine C, Galasko D, Bondi MW, Thal LJ, Salmon DP. PMID: 17983283.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    219. Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins. Nat Med. 2007 Nov; 13(11):1359-62. Ray S, Britschgi M, Herbert C, Takeda-Uchimura Y, Boxer A, Blennow K, Friedman LF, Galasko DR, Jutel M, Karydas A, Kaye JA, Leszek J, Miller BL, Minthon L, Quinn JF, Rabinovici GD, Robinson WH, Sabbagh MN, So YT, Sparks DL, Tabaton M, Tinklenberg J, Yesavage JA, Tibshirani R, Wyss-Coray T. PMID: 17934472.
      View in: PubMed   Mentions: 317     Fields:    Translation:Humans
    220. Diagnostic criteria for the behavioral variant of frontotemporal dementia (bvFTD): current limitations and future directions. Alzheimer Dis Assoc Disord. 2007 Oct-Dec; 21(4):S14-8. Rascovsky K, Hodges JR, Kipps CM, Johnson JK, Seeley WW, Mendez MF, Knopman D, Kertesz A, Mesulam M, Salmon DP, Galasko D, Chow TW, Decarli C, Hillis A, Josephs K, Kramer JH, Weintraub S, Grossman M, Gorno-Tempini ML, Miller BM. PMID: 18090417.
      View in: PubMed   Mentions: 67     Fields:    Translation:Humans
    221. Safety, tolerability, pharmacokinetics, and Abeta levels after short-term administration of R-flurbiprofen in healthy elderly individuals. Alzheimer Dis Assoc Disord. 2007 Oct-Dec; 21(4):292-9. Galasko DR, Graff-Radford N, May S, Hendrix S, Cottrell BA, Sagi SA, Mather G, Laughlin M, Zavitz KH, Swabb E, Golde TE, Murphy MP, Koo EH. PMID: 18090435.
      View in: PubMed   Mentions: 46     Fields:    Translation:HumansCTClinical Trials
    222. Pathological TDP-43 in parkinsonism-dementia complex and amyotrophic lateral sclerosis of Guam. Acta Neuropathol. 2008 Jan; 115(1):133-45. Geser F, Winton MJ, Kwong LK, Xu Y, Xie SX, Igaz LM, Garruto RM, Perl DP, Galasko D, Lee VM, Trojanowski JQ. PMID: 17713769.
      View in: PubMed   Mentions: 57     Fields:    Translation:HumansCells
    223. Quantitative proteomics identifies surfactant-resistant alpha-synuclein in cerebral cortex of Parkinsonism-dementia complex of Guam but not Alzheimer's disease or progressive supranuclear palsy. Am J Pathol. 2007 Sep; 171(3):993-1002. Yang W, Woltjer RL, Sokal I, Pan C, Wang Y, Brodey M, Peskind ER, Leverenz JB, Zhang J, Perl DP, Galasko DR, Montine TJ. PMID: 17675576.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    224. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol. 2007 Aug; 6(8):734-46. Dubois B, Feldman HH, Jacova C, Dekosky ST, Barberger-Gateau P, Cummings J, Delacourte A, Galasko D, Gauthier S, Jicha G, Meguro K, O'brien J, Pasquier F, Robert P, Rossor M, Salloway S, Stern Y, Visser PJ, Scheltens P. PMID: 17616482.
      View in: PubMed   Mentions: 882     Fields:    Translation:Humans
    225. Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases. Acta Neuropathol. 2007 Sep; 114(3):221-9. Nakashima-Yasuda H, Uryu K, Robinson J, Xie SX, Hurtig H, Duda JE, Arnold SE, Siderowf A, Grossman M, Leverenz JB, Woltjer R, Lopez OL, Hamilton R, Tsuang DW, Galasko D, Masliah E, Kaye J, Clark CM, Montine TJ, Lee VM, Trojanowski JQ. PMID: 17653732.
      View in: PubMed   Mentions: 132     Fields:    Translation:HumansCells
    226. Brain volumes in Guam dementia vs Parkinson dementia complex vs aging Chamorro adults. Neurology. 2007 Jul 10; 69(2):196-9. Kaye JA, Moore MM, Galasko D, Craig UK, Adonay R, Silbert LC. PMID: 17620553.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    227. The effects of prolonged stress and APOE genotype on memory and cortisol in older adults. Biol Psychiatry. 2007 Sep 01; 62(5):472-8. Peavy GM, Lange KL, Salmon DP, Patterson TL, Goldman S, Gamst AC, Mills PJ, Khandrika S, Galasko D. PMID: 17544378.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    228. Prevalence of dementia in Chamorros on Guam: relationship to age, gender, education, and APOE. Neurology. 2007 May 22; 68(21):1772-81. Galasko D, Salmon D, Gamst A, Olichney J, Thal LJ, Silbert L, Kaye J, Brooks P, Adonay R, Craig UK, Schellenberg G, Borenstein AR. PMID: 17515539.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    229. Cycad exposure and risk of dementia, MCI, and PDC in the Chamorro population of Guam. Neurology. 2007 May 22; 68(21):1764-71. Borenstein AR, Mortimer JA, Schofield E, Wu Y, Salmon DP, Gamst A, Olichney J, Thal LJ, Silbert L, Kaye J, Craig UL, Schellenberg GD, Galasko DR. PMID: 17515538.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansAnimalsPHPublic Health
    230. DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers. Neurology. 2007 Mar 13; 68(11):812-9. Lippa CF, Duda JE, Grossman M, Hurtig HI, Aarsland D, Boeve BF, Brooks DJ, Dickson DW, Dubois B, Emre M, Fahn S, Farmer JM, Galasko D, Galvin JE, Goetz CG, Growdon JH, Gwinn-Hardy KA, Hardy J, Heutink P, Iwatsubo T, Kosaka K, Lee VM, Leverenz JB, Masliah E, McKeith IG, Nussbaum RL, Olanow CW, Ravina BM, Singleton AB, Tanner CM, Trojanowski JQ, Wszolek ZK. PMID: 17353469.
      View in: PubMed   Mentions: 144     Fields:    Translation:Humans
    231. Disparate letter and semantic category fluency deficits in autopsy-confirmed frontotemporal dementia and Alzheimer's disease. Neuropsychology. 2007 Jan; 21(1):20-30. Rascovsky K, Salmon DP, Hansen LA, Thal LJ, Galasko D. PMID: 17201527.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    232. Two sites in the MAPT region confer genetic risk for Guam ALS/PDC and dementia. Hum Mol Genet. 2007 Feb 01; 16(3):295-306. Sundar PD, Yu CE, Sieh W, Steinbart E, Garruto RM, Oyanagi K, Craig UK, Bird TD, Wijsman EM, Galasko DR, Schellenberg GD. PMID: 17185385.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCells
    233. Effect of statins on Alzheimer's disease biomarkers in cerebrospinal fluid. J Alzheimers Dis. 2006 Dec; 10(4):399-406. Riekse RG, Li G, Petrie EC, Leverenz JB, Vavrek D, Vuletic S, Albers JJ, Montine TJ, Lee VM, Lee M, Seubert P, Galasko D, Schellenberg GD, Hazzard WR, Peskind ER. PMID: 17183151.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    234. The Uniform Data Set (UDS): clinical and cognitive variables and descriptive data from Alzheimer Disease Centers. Alzheimer Dis Assoc Disord. 2006 Oct-Dec; 20(4):210-6. Morris JC, Weintraub S, Chui HC, Cummings J, Decarli C, Ferris S, Foster NL, Galasko D, Graff-Radford N, Peskind ER, Beekly D, Ramos EM, Kukull WA. PMID: 17132964.
      View in: PubMed   Mentions: 320     Fields:    Translation:Humans
    235. ADCS Prevention Instrument Project: overview and initial results. Alzheimer Dis Assoc Disord. 2006 Oct-Dec; 20(4 Suppl 3):S109-23. Ferris SH, Aisen PS, Cummings J, Galasko D, Salmon DP, Schneider L, Sano M, Whitehouse PJ, Edland S, Thal LJ. PMID: 17135805.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansPHPublic Health
    236. ADCS Prevention Instrument Project: assessment of instrumental activities of daily living for community-dwelling elderly individuals in dementia prevention clinical trials. Alzheimer Dis Assoc Disord. 2006 Oct-Dec; 20(4 Suppl 3):S152-69. Galasko D, Bennett DA, Sano M, Marson D, Kaye J, Edland SD. PMID: 17135809.
      View in: PubMed   Mentions: 50     Fields:    Translation:HumansPHPublic Health
    237. Age and apolipoprotein E*4 allele effects on cerebrospinal fluid beta-amyloid 42 in adults with normal cognition. Arch Neurol. 2006 Jul; 63(7):936-9. Peskind ER, Li G, Shofer J, Quinn JF, Kaye JA, Clark CM, Farlow MR, DeCarli C, Raskind MA, Schellenberg GD, Lee VM, Galasko DR. PMID: 16831961.
      View in: PubMed   Mentions: 61     Fields:    Translation:Humans
    238. Robert Katzman honored. Alzheimer Dis Assoc Disord. 2006 Jul-Sep; 20(3 Suppl 2):S27-8. Thal LJ, Kawas C, Galasko D, Salmon DP, Sundsmo MP. PMID: 16917190.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    239. Characterization of tau pathologies in gray and white matter of Guam parkinsonism-dementia complex. Acta Neuropathol. 2006 May; 111(5):401-12. Winton MJ, Joyce S, Zhukareva V, Practico D, Perl DP, Galasko D, Craig U, Trojanowski JQ, Lee VM. PMID: 16609851.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    240. Cognitive profiles of individual patients with Parkinson's disease and dementia: comparison with dementia with lewy bodies and Alzheimer's disease. Mov Disord. 2006 Mar; 21(3):337-42. Janvin CC, Larsen JP, Salmon DP, Galasko D, Hugdahl K, Aarsland D. PMID: 16211595.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    241. The role of biomarkers in clinical trials for Alzheimer disease. Alzheimer Dis Assoc Disord. 2006 Jan-Mar; 20(1):6-15. Thal LJ, Kantarci K, Reiman EM, Klunk WE, Weiner MW, Zetterberg H, Galasko D, Praticò D, Griffin S, Schenk D, Siemers E. PMID: 16493230.
      View in: PubMed   Mentions: 68     Fields:    Translation:Humans
    242. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology. 2005 Dec 27; 65(12):1863-72. McKeith IG, Dickson DW, Lowe J, Emre M, O'Brien JT, Feldman H, Cummings J, Duda JE, Lippa C, Perry EK, Aarsland D, Arai H, Ballard CG, Boeve B, Burn DJ, Costa D, Del Ser T, Dubois B, Galasko D, Gauthier S, Goetz CG, Gomez-Tortosa E, Halliday G, Hansen LA, Hardy J, Iwatsubo T, Kalaria RN, Kaufer D, Kenny RA, Korczyn A, Kosaka K, Lee VM, Lees A, Litvan I, Londos E, Lopez OL, Minoshima S, Mizuno Y, Molina JA, Mukaetova-Ladinska EB, Pasquier F, Perry RH, Schulz JB, Trojanowski JQ, Yamada M. PMID: 16237129.
      View in: PubMed   Mentions: 1162     Fields:    Translation:HumansCells
    243. Safety and acceptability of the research lumbar puncture. Alzheimer Dis Assoc Disord. 2005 Oct-Dec; 19(4):220-5. Peskind ER, Riekse R, Quinn JF, Kaye J, Clark CM, Farlow MR, Decarli C, Chabal C, Vavrek D, Raskind MA, Galasko D. PMID: 16327349.
      View in: PubMed   Mentions: 55     Fields:    Translation:Humans
    244. Lack of beta-methylamino-l-alanine in brain from controls, AD, or Chamorros with PDC. Neurology. 2005 Sep 13; 65(5):768-9. Montine TJ, Li K, Perl DP, Galasko D. PMID: 16157919.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansPHPublic Health
    245. Rate of progression differs in frontotemporal dementia and Alzheimer disease. Neurology. 2005 Aug 09; 65(3):397-403. Rascovsky K, Salmon DP, Lipton AM, Leverenz JB, DeCarli C, Jagust WJ, Clark CM, Mendez MF, Tang-Wai DF, Graff-Radford NR, Galasko D. PMID: 16087904.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    246. Detailed assessment of activities of daily living in moderate to severe Alzheimer's disease. J Int Neuropsychol Soc. 2005 Jul; 11(4):446-53. Galasko D, Schmitt F, Thomas R, Jin S, Bennett D. PMID: 16209425.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    247. Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl J Med. 2005 Jun 09; 352(23):2379-88. Petersen RC, Thomas RG, Grundman M, Bennett D, Doody R, Ferris S, Galasko D, Jin S, Kaye J, Levey A, Pfeiffer E, Sano M, van Dyck CH, Thal LJ. PMID: 15829527.
      View in: PubMed   Mentions: 450     Fields:    Translation:HumansCTClinical Trials
    248. Biomarkers for Alzheimer's disease--clinical needs and application. J Alzheimers Dis. 2005 Mar; 8(4):339-46. Galasko D. PMID: 16556965.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansPHPublic Health
    249. Consensus paper of the WFSBP Task Force on Biological Markers of Dementia: the role of CSF and blood analysis in the early and differential diagnosis of dementia. World J Biol Psychiatry. 2005; 6(2):69-84. Wiltfang J, Lewczuk P, Riederer P, Grünblatt E, Hock C, Scheltens P, Hampel H, Vanderstichele H, Iqbal K, Galasko D, Lannfelt L, Otto M, Esselmann H, Henkel AW, Kornhuber J, Blennow K. PMID: 16156480.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCells
    250. A comparison of episodic memory deficits in neuropathologically-confirmed Dementia with Lewy bodies and Alzheimer's disease. J Int Neuropsychol Soc. 2004 Sep; 10(5):689-97. Hamilton JM, Salmon DP, Galasko D, Delis DC, Hansen LA, Masliah E, Thomas RG, Thal LJ. PMID: 15327716.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCells
    251. Role of LRP in TGFbeta2-mediated neuronal uptake of Abeta and effects on memory. J Neurosci Res. 2004 Jul 15; 77(2):217-28. Harris-White ME, Balverde Z, Lim GP, Kim P, Miller SA, Hammer H, Galasko D, Frautschy SA. PMID: 15211588.
      View in: PubMed   Mentions: 10     Fields:    Translation:AnimalsCells
    252. Galantamine maintains ability to perform activities of daily living in patients with Alzheimer's disease. J Am Geriatr Soc. 2004 Jul; 52(7):1070-6. Galasko D, Kershaw PR, Schneider L, Zhu Y, Tariot PN. PMID: 15209643.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCTClinical Trials
    253. Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials. Arch Neurol. 2004 Jan; 61(1):59-66. Grundman M, Petersen RC, Ferris SH, Thomas RG, Aisen PS, Bennett DA, Foster NL, Jack CR, Galasko DR, Doody R, Kaye J, Sano M, Mohs R, Gauthier S, Kim HT, Jin S, Schultz AN, Schafer K, Mulnard R, van Dyck CH, Mintzer J, Zamrini EY, Cahn-Weiner D, Thal LJ. PMID: 14732621.
      View in: PubMed   Mentions: 211     Fields:    Translation:HumansCTClinical Trials
    254. Cerebrospinal fluid tau and beta-amyloid: how well do these biomarkers reflect autopsy-confirmed dementia diagnoses? Arch Neurol. 2003 Dec; 60(12):1696-702. Clark CM, Xie S, Chittams J, Ewbank D, Peskind E, Galasko D, Morris JC, McKeel DW, Farlow M, Weitlauf SL, Quinn J, Kaye J, Knopman D, Arai H, Doody RS, DeCarli C, Leight S, Lee VM, Trojanowski JQ. PMID: 14676043.
      View in: PubMed   Mentions: 117     Fields:    Translation:Humans
    255. Neuromotor abnormalities and risk for psychosis in Alzheimer's disease. Neurology. 2003 Oct 14; 61(7):954-8. Caligiuri MP, Peavy G, Salmon DP, Galasko DR, Thal LJ. PMID: 14557567.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    256. Performance on the dementia rating scale in Parkinson's disease with dementia and dementia with Lewy bodies: comparison with progressive supranuclear palsy and Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2003 Sep; 74(9):1215-20. Aarsland D, Litvan I, Salmon D, Galasko D, Wentzel-Larsen T, Larsen JP. PMID: 12933921.
      View in: PubMed   Mentions: 40     Fields:    Translation:Humans
    257. Cerebrospinal fluid biomarkers in Alzheimer disease: a fractional improvement? Arch Neurol. 2003 Sep; 60(9):1195-6. Galasko D. PMID: 12975282.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    258. Abeta1-42 promotes cholinergic sprouting in patients with AD and Lewy body variant of AD. Neurology. 2003 Jul 22; 61(2):206-11. Masliah E, Alford M, Adame A, Rockenstein E, Galasko D, Salmon D, Hansen LA, Thal LJ. PMID: 12874400.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCells
    259. Biological markers for therapeutic trials in Alzheimer's disease. Proceedings of the biological markers working group; NIA initiative on neuroimaging in Alzheimer's disease. Neurobiol Aging. 2003 Jul-Aug; 24(4):521-36. Frank RA, Galasko D, Hampel H, Hardy J, de Leon MJ, Mehta PD, Rogers J, Siemers E, Trojanowski JQ. PMID: 12714109.
      View in: PubMed   Mentions: 62     Fields:    Translation:HumansAnimals
    260. Insulin and Alzheimer's disease: an amyloid connection. Neurology. 2003 Jun 24; 60(12):1886-7. Galasko D. PMID: 12821727.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    261. Influence of Alzheimer pathology on clinical diagnostic accuracy in dementia with Lewy bodies. Neurology. 2003 May 27; 60(10):1586-90. Merdes AR, Hansen LA, Jeste DV, Galasko D, Hofstetter CR, Ho GJ, Thal LJ, Corey-Bloom J. PMID: 12771246.
      View in: PubMed   Mentions: 68     Fields:    Translation:HumansCells
    262. Tropicamide effects on pupil size and pupillary light reflexes in Alzheimer's and Parkinson's disease. Int J Psychophysiol. 2003 Feb; 47(2):95-115. Granholm E, Morris S, Galasko D, Shults C, Rogers E, Vukov B. PMID: 12568941.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCTClinical Trials
    263. Amyotrophic lateral sclerosis and parkinsonism-dementia complex of Guam: changing incidence rates during the past 60 years. Am J Epidemiol. 2003 Jan 15; 157(2):149-57. Plato CC, Garruto RM, Galasko D, Craig UK, Plato M, Gamst A, Torres JM, Wiederholt W. PMID: 12522022.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    264. Decline in verbal memory during preclinical Alzheimer's disease: examination of the effect of APOE genotype. J Int Neuropsychol Soc. 2002 Nov; 8(7):943-55. Lange KL, Bondi MW, Salmon DP, Galasko D, Delis DC, Thomas RG, Thal LJ. PMID: 12405546.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    265. Age at onset is associated with disease severity in Lewy body variant and Alzheimer's disease. Neuroreport. 2002 Oct 07; 13(14):1825-8. Ho GJ, Hansen LA, Alford MF, Foster K, Salmon DP, Galasko D, Thal LJ, Masliah E. PMID: 12395133.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    266. Cognitive profiles differ in autopsy-confirmed frontotemporal dementia and AD. Neurology. 2002 Jun 25; 58(12):1801-8. Rascovsky K, Salmon DP, Ho GJ, Galasko D, Peavy GM, Hansen LA, Thal LJ. PMID: 12084880.
      View in: PubMed   Mentions: 53     Fields:    Translation:Humans
    267. Picking away at frontotemporal dementia. Neurology. 2002 Jun 11; 58(11):1585-6. Galasko D, Marder K. PMID: 12058081.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    268. Defective neuronal sprouting by human apolipoprotein E4 is a gain-of-negative function. J Neurosci Res. 2002 May 01; 68(3):331-6. Teter B, Xu PT, Gilbert JR, Roses AD, Galasko D, Cole GM. PMID: 12111863.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansAnimalsCells
    269. Effect of extrapyramidal signs and Lewy bodies on survival in patients with Alzheimer disease. Arch Neurol. 2002 Apr; 59(4):588-93. Haan MN, Jagust WJ, Galasko D, Kaye J. PMID: 11939893.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    270. ALS and PDC of Guam: forty-year follow-up. Neurology. 2002 Mar 12; 58(5):765-73. Plato CC, Galasko D, Garruto RM, Plato M, Gamst A, Craig UK, Torres JM, Wiederholt W. PMID: 11889241.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    271. Intracellular Abeta is increased by okadaic acid exposure in transfected neuronal and non-neuronal cell lines. Neurobiol Aging. 2002 Mar-Apr; 23(2):195-203. Sun X, Cole GM, Chu T, Xia W, Galasko D, Yamaguchi H, Tanemura K, Frautschy SA, Takashima A. PMID: 11804703.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimalsCells
    272. Clinical features and changing patterns of neurodegenerative disorders on Guam, 1997-2000. Neurology. 2002 Jan 08; 58(1):90-7. Galasko D, Salmon DP, Craig UK, Thal LJ, Schellenberg G, Wiederholt W. PMID: 11781411.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    273. No long-term effect of behavioral treatment on psychotropic drug use for agitation in Alzheimer's disease patients. J Geriatr Psychiatry Neurol. 2002; 15(2):95-8. Weiner MF, Tractenberg RE, Sano M, Logsdon R, Teri L, Galasko D, Gamst A, Thomas R, Thal LJ. PMID: 12083600.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    274. Cholinergic deficits in the brains of patients with parkinsonism-dementia complex of Guam. Neuroreport. 2001 Dec 21; 12(18):3901-3. Masliah E, Alford M, Galasko D, Salmon D, Hansen LA, Good PF, Perl DP, Thal L. PMID: 11742207.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    275. Rate of cognitive change in Alzheimer's disease: methodological approaches using random effects models. J Int Neuropsychol Soc. 2001 Nov; 7(7):813-24. Gould R, Abramson I, Galasko D, Salmon D. PMID: 11771624.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    276. TAU as a susceptibility gene for amyotropic lateral sclerosis-parkinsonism dementia complex of Guam. Arch Neurol. 2001 Nov; 58(11):1871-8. Poorkaj P, Tsuang D, Wijsman E, Steinbart E, Garruto RM, Craig UK, Chapman NH, Anderson L, Bird TD, Plato CC, Perl DP, Weiderholt W, Galasko D, Schellenberg GD. PMID: 11708997.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    277. Biological markers and the treatment of Alzheimer's disease. J Mol Neurosci. 2001 Oct; 17(2):119-25. Galasko D. PMID: 11816785.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    278. Altered expression of the synuclein family mRNA in Lewy body and Alzheimer's disease. Brain Res. 2001 Sep 28; 914(1-2):48-56. Rockenstein E, Hansen LA, Mallory M, Trojanowski JQ, Galasko D, Masliah E. PMID: 11578596.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    279. Lewy bodies and dementia. Curr Neurol Neurosci Rep. 2001 Sep; 1(5):435-41. Galasko D. PMID: 11898554.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    280. Extrapyramidal signs and cognitive abilities in Alzheimer's disease. Int J Geriatr Psychiatry. 2001 Sep; 16(9):907-11. Caligiuri MP, Peavy G, Galasko DR. PMID: 11571772.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    281. New approaches to diagnose and treat Alzheimer's disease: a glimpse of the future. Clin Geriatr Med. 2001 May; 17(2):393-410. Galasko D. PMID: 11375142.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimalsPHPublic Health
    282. Frequency of tau gene mutations in familial and sporadic cases of non-Alzheimer dementia. Arch Neurol. 2001 Mar; 58(3):383-7. Poorkaj P, Grossman M, Steinbart E, Payami H, Sadovnick A, Nochlin D, Tabira T, Trojanowski JQ, Borson S, Galasko D, Reich S, Quinn B, Schellenberg G, Bird TD. PMID: 11255441.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansCells
    283. Loss of brain tau defines novel sporadic and familial tauopathies with frontotemporal dementia. Ann Neurol. 2001 Feb; 49(2):165-75. Zhukareva V, Vogelsberg-Ragaglia V, Van Deerlin VM, Bruce J, Shuck T, Grossman M, Clark CM, Arnold SE, Masliah E, Galasko D, Trojanowski JQ, Lee VM. PMID: 11220736.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    284. Amyloid-beta and treatment opportunities for Alzheimer's disease. J Alzheimers Dis. 2000 Nov; 2(3-4):231-59. Sabbagh MN, Galasko D, Koo E, Thal LJ. PMID: 12214087.
      View in: PubMed   Mentions: 1     Fields:    
    285. Part V. Genetic advances and biological markers for Alzheimer's disease. Dis Mon. 2000 Nov; 46(11):731-43. Galasko DR. PMID: 11130324.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    286. Better cognitive and psychopathologic response to donepezil in patients prospectively diagnosed as dementia with Lewy bodies: a preliminary study. Int J Geriatr Psychiatry. 2000 Sep; 15(9):794-802. Samuel W, Caligiuri M, Galasko D, Lacro J, Marini M, McClure FS, Warren K, Jeste DV. PMID: 10984725.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCTClinical Trials
    287. Psychopathology at initial diagnosis in dementia with Lewy bodies versus Alzheimer disease: comparison of matched groups with autopsy-confirmed diagnoses. Int J Geriatr Psychiatry. 2000 Sep; 15(9):819-23. Rockwell E, Choure J, Galasko D, Olichney J, Jeste DV. PMID: 10984728.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    288. Measuring cognitive change in a cohort of patients with Alzheimer's disease. Stat Med. 2000 Jun 15-30; 19(11-12):1421-32. Galasko DR, Gould RL, Abramson IS, Salmon DP. PMID: 10844707.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    289. Incidence of and risk factors for hallucinations and delusions in patients with probable AD. Neurology. 2000 May 23; 54(10):1965-71. Paulsen JS, Salmon DP, Thal LJ, Romero R, Weisstein-Jenkins C, Galasko D, Hofstetter CR, Thomas R, Grant I, Jeste DV. PMID: 10822438.
      View in: PubMed   Mentions: 44     Fields:    Translation:Humans
    290. Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: Their Role in Clinical Chemistry. EJIFCC. 2000 Mar; 12(1):11-20. Blennow K, Galasko D. PMID: 30675139.
      View in: PubMed   Mentions:
    291. Amyloid-beta peptides interact with plasma proteins and erythrocytes: implications for their quantitation in plasma. Biochem Biophys Res Commun. 2000 Feb 24; 268(3):750-6. Kuo YM, Kokjohn TA, Kalback W, Luehrs D, Galasko DR, Chevallier N, Koo EH, Emmerling MR, Roher AE. PMID: 10679277.
      View in: PubMed   Mentions: 52     Fields:    Translation:HumansCells
    292. The clinical spectrum of Guam ALS and Parkinson-dementia complex: 1997-1999. Ann N Y Acad Sci. 2000; 920:120-5. Galasko D, Salmon D, Craig UK, Wiederholt W. PMID: 11193140.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    293. Human apolipoprotein E isoform-specific differences in neuronal sprouting in organotypic hippocampal culture. J Neurochem. 1999 Dec; 73(6):2613-6. Teter B, Xu PT, Gilbert JR, Roses AD, Galasko D, Cole GM. PMID: 10582625.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansAnimalsCells
    294. Effects of time and cholinesterase inhibitor treatment on multiple cerebrospinal fluid parameters in Alzheimer's disease. Methods Find Exp Clin Pharmacol. 1999 Oct; 21(8):549-54. Moriearty PL, Seubert P, Galasko D, Markwell S, Unni L, Vicari S, Becker RE. PMID: 10599054.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCellsCTClinical Trials
    295. Longitudinal stability of CSF tau levels in Alzheimer patients. Biol Psychiatry. 1999 Sep 15; 46(6):750-5. Sunderland T, Wolozin B, Galasko D, Levy J, Dukoff R, Bahro M, Lasser R, Motter R, Lehtimäki T, Seubert P. PMID: 10494442.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    296. Variability in annual Mini-Mental State Examination score in patients with probable Alzheimer disease: a clinical perspective of data from the Consortium to Establish a Registry for Alzheimer's Disease. Arch Neurol. 1999 Jul; 56(7):857-62. Clark CM, Sheppard L, Fillenbaum GG, Galasko D, Morris JC, Koss E, Mohs R, Heyman A. PMID: 10404988.
      View in: PubMed   Mentions: 45     Fields:    Translation:HumansCTClinical Trials
    297. Rehabilitation of hemiparesis after stroke with a mirror. Lancet. 1999 Jun 12; 353(9169):2035-6. Altschuler EL, Wisdom SB, Stone L, Foster C, Galasko D, Llewellyn DM, Ramachandran VS. PMID: 10376620.
      View in: PubMed   Mentions: 84     Fields:    Translation:HumansCTClinical Trials
    298. Cerebrospinal fluid opens a window on Alzheimer disease. Arch Neurol. 1999 Jun; 56(6):655-6. Galasko D. PMID: 10369301.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    299. Neuropsychological function and apolipoprotein E genotype in the preclinical detection of Alzheimer's disease. Psychol Aging. 1999 Jun; 14(2):295-303. Bondi MW, Salmon DP, Galasko D, Thomas RG, Thal LJ. PMID: 10403716.
      View in: PubMed   Mentions: 63     Fields:    Translation:HumansCTClinical Trials
    300. Retraction. Proc Natl Acad Sci U S A. 1998 09 29; 95(20):12069. Davis RE, Miller S, Herrnstadt C, Ghosh SS, Fahy E, Shinobu LA, Galasko D, Thal LJ, Beal MF, Howell N, Parker WD. PMID: 16578857.
      View in: PubMed   Mentions: 2     Fields:    
    301. Cerebrospinal fluid tau protein is not elevated in HIV-associated neurologic disease in humans. HIV Neurobehavioral Research Center Group (HNRC). Neurosci Lett. 1998 Sep 18; 254(1):1-4. Ellis RJ, Seubert P, Motter R, Galasko D, Deutsch R, Heaton RK, Heyes MP, McCutchan JA, Atkinson JH, Grant I. PMID: 9780077.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    302. Pronounced impact of Th1/E47cs mutation compared with -491 AT mutation on neural APOE gene expression and risk of developing Alzheimer's disease. Hum Mol Genet. 1998 Sep; 7(9):1511-6. Lambert JC, Berr C, Pasquier F, Delacourte A, Frigard B, Cottel D, Pérez-Tur J, Mouroux V, Mohr M, Cécyre D, Galasko D, Lendon C, Poirier J, Hardy J, Mann D, Amouyel P, Chartier-Harlin MC. PMID: 9700208.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansCells
    303. Prostaglandin E2 induced polymerization of human alpha-1-antichymotrypsin and suppressed its protease inhibitory activity: implications for Alzheimer's disease. Biochem Biophys Res Commun. 1998 Aug 10; 249(1):182-6. Licastro F, Davis LJ, Pedrini S, Galasko D, Masliah E. PMID: 9705853.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    304. Cognitive decline is faster in Lewy body variant than in Alzheimer's disease. Neurology. 1998 Aug; 51(2):351-7. Olichney JM, Galasko D, Salmon DP, Hofstetter CR, Hansen LA, Katzman R, Thal LJ. PMID: 9710002.
      View in: PubMed   Mentions: 71     Fields:    Translation:HumansCTClinical Trials
    305. Cognitive profiles of autopsy-confirmed Lewy body variant vs pure Alzheimer disease. Arch Neurol. 1998 Jul; 55(7):994-1000. Connor DJ, Salmon DP, Sandy TJ, Galasko D, Hansen LA, Thal LJ. PMID: 9678318.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansCTClinical Trials
    306. High cerebrospinal fluid tau and low amyloid beta42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotype. Arch Neurol. 1998 Jul; 55(7):937-45. Galasko D, Chang L, Motter R, Clark CM, Kaye J, Knopman D, Thomas R, Kholodenko D, Schenk D, Lieberburg I, Miller B, Green R, Basherad R, Kertiles L, Boss MA, Seubert P. PMID: 9678311.
      View in: PubMed   Mentions: 95     Fields:    Translation:HumansCTClinical Trials
    307. The role of apolipoprotein E testing in the diagnosis of Alzheimer's disease. West J Med. 1998 Apr; 168(4):264-5. Galasko D. PMID: 9584668.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    308. CSF tau and Abeta42: logical biomarkers for Alzheimer's disease? Neurobiol Aging. 1998 Mar-Apr; 19(2):117-9. Galasko D. PMID: 9558144.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    309. Cerebrospinal fluid levels of A beta 42 and tau: potential markers of Alzheimer's disease. J Neural Transm Suppl. 1998; 53:209-21. Galasko D. PMID: 9700659.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    310. Distortion of allelic expression of apolipoprotein E in Alzheimer's disease. Hum Mol Genet. 1997 Nov; 6(12):2151-4. Lambert JC, Pérez-Tur J, Dupire MJ, Galasko D, Mann D, Amouyel P, Hardy J, Delacourte A, Chartier-Harlin MC. PMID: 9328480.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    311. Early-onset Alzheimer's disease with a presenilin-1 mutation at the site corresponding to the Volga German presenilin-2 mutation. Ann Neurol. 1997 Jul; 42(1):124-8. Crook R, Ellis R, Shanks M, Thal LJ, Perez-Tur J, Baker M, Hutton M, Haltia T, Hardy J, Galasko D. PMID: 9225696.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    312. The impact of apolipoprotein E4 on cause of death in Alzheimer's disease. Neurology. 1997 Jul; 49(1):76-81. Olichney JM, Sabbagh MN, Hofstetter CR, Galasko D, Grundman M, Katzman R, Thal LJ. PMID: 9222173.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    313. Mutations in mitochondrial cytochrome c oxidase genes segregate with late-onset Alzheimer disease. Proc Natl Acad Sci U S A. 1997 Apr 29; 94(9):4526-31. Davis RE, Miller S, Herrnstadt C, Ghosh SS, Fahy E, Shinobu LA, Galasko D, Thal LJ, Beal MF, Howell N, Parker WD. PMID: 9114023.
      View in: PubMed   Mentions: 59     Fields:    Translation:HumansCells
    314. Assessment of CSF levels of tau protein in mildly demented patients with Alzheimer's disease. Neurology. 1997 Mar; 48(3):632-5. Galasko D, Clark C, Chang L, Miller B, Green RC, Motter R, Seubert P. PMID: 9065538.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCTClinical Trials
    315. The tau protein in human cerebrospinal fluid in Alzheimer's disease consists of proteolytically derived fragments. J Neurochem. 1997 Jan; 68(1):430-3. Johnson GV, Seubert P, Cox TM, Motter R, Brown JP, Galasko D. PMID: 8978756.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    316. Multicenter evaluation of new instruments for Alzheimer's disease clinical trials: summary of results. The Alzheimer's Disease Cooperative Study. Alzheimer Dis Assoc Disord. 1997; 11 Suppl 2:S65-9. Mackell JA, Ferris SH, Mohs R, Schneider L, Galasko D, Whitehouse P, Schmitt F, Sano M, Thal LJ. PMID: 9236955.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    317. A multicenter evaluation of new treatment efficacy instruments for Alzheimer's disease clinical trials: overview and general results. The Alzheimer's Disease Cooperative Study. Alzheimer Dis Assoc Disord. 1997; 11 Suppl 2:S1-12. Ferris SH, Mackell JA, Mohs R, Schneider LS, Galasko D, Whitehouse PJ, Schmitt FA, Sano M, Thomas RG, Ernesto C, Grundman M, Schafer K, Thal LJ. PMID: 9236947.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCTClinical Trials
    318. An inventory to assess activities of daily living for clinical trials in Alzheimer's disease. The Alzheimer's Disease Cooperative Study. Alzheimer Dis Assoc Disord. 1997; 11 Suppl 2:S33-9. Galasko D, Bennett D, Sano M, Ernesto C, Thomas R, Grundman M, Ferris S. PMID: 9236950.
      View in: PubMed   Mentions: 245     Fields:    Translation:HumansCTClinical Trials
    319. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology. 1996 Nov; 47(5):1113-24. McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, Salmon DP, Lowe J, Mirra SS, Byrne EJ, Lennox G, Quinn NP, Edwardson JA, Ince PG, Bergeron C, Burns A, Miller BL, Lovestone S, Collerton D, Jansen EN, Ballard C, de Vos RA, Wilcock GK, Jellinger KA, Perry RH. PMID: 8909416.
      View in: PubMed   Mentions: 615     Fields:    Translation:Humans
    320. ApoE and CYP2D6 polymorphism with and without parkinsonism-dementia complex in the people of Chamorro, guam. Neurology. 1996 Sep; 47(3):779-84. Chen X, Xia Y, Gresham LS, Molgaard CA, Thomas RG, Galasko D, Wiederholt WC, Saitoh T. PMID: 8797479.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    321. Neuropsychological deficits associated with diffuse Lewy body disease. Brain Cogn. 1996 Jul; 31(2):148-65. Salmon DP, Galasko D, Hansen LA, Masliah E, Butters N, Thal LJ, Katzman R. PMID: 8811990.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    322. Clinical and neuropathological findings in Lewy body dementias. Brain Cogn. 1996 Jul; 31(2):166-75. Galasko D, Katzman R, Salmon DP, Hansen L. PMID: 8811993.
      View in: PubMed   Mentions: 39     Fields:    Translation:Humans
    323. The apolipoprotein E epsilon 4 allele is associated with increased neuritic plaques and cerebral amyloid angiopathy in Alzheimer's disease and Lewy body variant. Neurology. 1996 Jul; 47(1):190-6. Olichney JM, Hansen LA, Galasko D, Saitoh T, Hofstetter CR, Katzman R, Thal LJ. PMID: 8710076.
      View in: PubMed   Mentions: 48     Fields:    Translation:HumansCells
    324. Neuropsychological assessment of severely demeted elderly: the severe cognitive impairment profile. Arch Neurol. 1996 Apr; 53(4):367-72. Peavy GM, Salmon DP, Rice VA, Galasko D, Samuel W, Taylor KI, Ernesto C, Butters N, Thal L. PMID: 8929160.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    325. Apolipoprotein-epsilon4 and head trauma: Synergistic or additive risks? Neurology. 1996 Mar; 46(3):889-91. Katzman R, Galasko DR, Saitoh T, Chen X, Pay MM, Booth A, Thomas RG. PMID: 8618734.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    326. Neocortical lewy body counts correlate with dementia in the Lewy body variant of Alzheimer's disease. J Neuropathol Exp Neurol. 1996 Jan; 55(1):44-52. Samuel W, Galasko D, Masliah E, Hansen LA. PMID: 8558171.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    327. Clinical and neuropsychological differences between patients with earlier and later onset of Alzheimer's disease: A CERAD analysis, Part XII. Neurology. 1996 Jan; 46(1):136-41. Koss E, Edland S, Fillenbaum G, Mohs R, Clark C, Galasko D, Morris JC. PMID: 8559362.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    328. Extrapyramidal motor signs in clinically diagnosed Alzheimer disease. Alzheimer Dis Assoc Disord. 1996; 10(2):103-14. Ellis RJ, Caligiuri M, Galasko D, Thal LJ. PMID: 8727172.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    329. Episodic memory changes are associated with the APOE-epsilon 4 allele in nondemented older adults. Neurology. 1995 Dec; 45(12):2203-6. Bondi MW, Salmon DP, Monsch AU, Galasko D, Butters N, Klauber MR, Thal LJ, Saitoh T. PMID: 8848194.
      View in: PubMed   Mentions: 55     Fields:    Translation:Humans
    330. Lewy body dementia--diagnosis and treatment. Br J Psychiatry. 1995 Dec; 167(6):709-17. McKeith IG, Galasko D, Wilcock GK, Byrne EJ. PMID: 8829735.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    331. Reduction of beta-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease. Ann Neurol. 1995 Oct; 38(4):643-8. Motter R, Vigo-Pelfrey C, Kholodenko D, Barbour R, Johnson-Wood K, Galasko D, Chang L, Miller B, Clark C, Green R. PMID: 7574461.
      View in: PubMed   Mentions: 117     Fields:    Translation:HumansCells
    332. Adjunctive therapy in patients with Alzheimer's disease. A practical approach. Drugs Aging. 1995 Aug; 7(2):79-87. Corey-Bloom J, Galasko D. PMID: 7579786.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    333. Genetic evidence that the Lewy body variant is indeed a phenotypic variant of Alzheimer's disease. Brain Cogn. 1995 Aug; 28(3):259-65. Katzman R, Galasko D, Saitoh T, Thal LJ, Hansen L. PMID: 8546853.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    334. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part XI. Clinical milestones in patients with Alzheimer's disease followed over 3 years. Neurology. 1995 Aug; 45(8):1451-5. Galasko D, Edland SD, Morris JC, Clark C, Mohs R, Koss E. PMID: 7644039.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    335. Death certificate reporting of dementia and mortality in an Alzheimer's disease research center cohort. J Am Geriatr Soc. 1995 Aug; 43(8):890-3. Olichney JM, Hofstetter CR, Galasko D, Thal LJ, Katzman R. PMID: 7636097.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    336. A fibroblast growth factor binding protein in human cerebral spinal fluid. Neuroreport. 1995 Apr 19; 6(6):886-8. Hanneken A, Frautschy S, Galasko D, Baird A. PMID: 7612876.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    337. Diagnosis and evaluation of dementia. Neurology. 1995 Feb; 45(2):211-8. Corey-Bloom J, Thal LJ, Galasko D, Folstein M, Drachman D, Raskind M, Lanska DJ. PMID: 7854514.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    338. The spectrum of diseases with diffuse Lewy bodies. Adv Neurol. 1995; 65:159-70. Olichney JM, Galasko D, Corey-Bloom J, Thal LJ. PMID: 7872137.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    339. The CYP2D6B mutant allele is overrepresented in the Lewy body variant of Alzheimer's disease. Ann Neurol. 1995 Jan; 37(1):110-2. Saitoh T, Xia Y, Chen X, Masliah E, Galasko D, Shults C, Thal LJ, Hansen LA, Katzman R. PMID: 7818242.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    340. Apolipoprotein-E epsilon-4 is associated with increased neurofibrillary pathology in the Lewy body variant of Alzheimer's disease. Neurosci Lett. 1994 Nov 21; 182(1):63-5. Hansen LA, Galasko D, Samuel W, Xia Y, Chen X, Saitoh T. PMID: 7891889.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    341. The apolipoprotein E allele epsilon 4 is overrepresented in patients with the Lewy body variant of Alzheimer's disease. Neurology. 1994 Oct; 44(10):1950-1. Galasko D, Saitoh T, Xia Y, Thal LJ, Katzman R, Hill LR, Hansen L. PMID: 7936253.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    342. Clinical-neuropathological correlations in Alzheimer's disease and related dementias. Arch Neurol. 1994 Sep; 51(9):888-95. Galasko D, Hansen LA, Katzman R, Wiederholt W, Masliah E, Terry R, Hill LR, Lessin P, Thal LJ. PMID: 8080388.
      View in: PubMed   Mentions: 62     Fields:    Translation:Humans
    343. Selective rubella vaccination programmes: a survey of districts in England and Wales. Commun Dis Rep CDR Rev. 1994 Jun 24; 4(7):R77-9. Gay NJ, Valambia S, Galasko D, Miller E. PMID: 7520802.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    344. The consortium to establish a registry for Alzheimer's disease (CERAD). Part IV. Rates of cognitive change in the longitudinal assessment of probable Alzheimer's disease. Neurology. 1993 Dec; 43(12):2457-65. Morris JC, Edland S, Clark C, Galasko D, Koss E, Mohs R, van Belle G, Fillenbaum G, Heyman A. PMID: 8255439.
      View in: PubMed   Mentions: 73     Fields:    Translation:Humans
    345. Plaque-only Alzheimer disease is usually the lewy body variant, and vice versa. J Neuropathol Exp Neurol. 1993 Nov; 52(6):648-54. Hansen LA, Masliah E, Galasko D, Terry RD. PMID: 8229084.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansCells
    346. Neurotransmitters in basal ganglia and cortex of Alzheimer's disease with and without Lewy bodies. Neurology. 1993 Oct; 43(10):1927-34. Langlais PJ, Thal L, Hansen L, Galasko D, Alford M, Masliah E. PMID: 8105420.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCells
    347. Repeated exposure to the Mini-Mental State Examination and the Information-Memory-Concentration Test results in a practice effect in Alzheimer's disease. Neurology. 1993 Aug; 43(8):1559-63. Galasko D, Abramson I, Corey-Bloom J, Thal LJ. PMID: 8351011.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    348. Secretion of beta-amyloid precursor protein cleaved at the amino terminus of the beta-amyloid peptide. Nature. 1993 Jan 21; 361(6409):260-3. Seubert P, Oltersdorf T, Lee MG, Barbour R, Blomquist C, Davis DL, Bryant K, Fritz LC, Galasko D, Thal LJ. PMID: 7678698.
      View in: PubMed   Mentions: 80     Fields:    Translation:HumansCells
    349. Clinical features distinguishing large cohorts with possible AD, probable AD, and mixed dementia. J Am Geriatr Soc. 1993 Jan; 41(1):31-7. Corey-Bloom J, Galasko D, Hofstetter CR, Jackson JE, Thal LJ. PMID: 8418119.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansPHPublic Health
    350. Lewy body disease. Curr Opin Neurol Neurosurg. 1992 Dec; 5(6):889-94. Hansen LA, Galasko D. PMID: 1467583.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    351. Quantifying drug-induced changes in parkinsonian rigidity using an instrumental measure of activated stiffness. Clin Neuropharmacol. 1992 Feb; 15(1):1-12. Caligiuri MP, Galasko DR. PMID: 1576594.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    352. Monitoring progression in Alzheimer's disease. J Am Geriatr Soc. 1991 Sep; 39(9):932-41. Galasko D, Corey-Bloom J, Thal LJ. PMID: 1842209.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    353. Stimulated platelets release amyloid beta-protein precursor. Biochem Biophys Res Commun. 1990 Jul 16; 170(1):288-95. Cole GM, Galasko D, Shapiro IP, Saitoh T. PMID: 2115331.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    354. Neurological findings in Alzheimer's disease and normal aging. Arch Neurol. 1990 Jun; 47(6):625-7. Galasko D, Kwo-on-Yuen PF, Klauber MR, Thal LJ. PMID: 2346387.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    355. The Lewy body variant of Alzheimer's disease: a clinical and pathologic entity. Neurology. 1990 Jan; 40(1):1-8. Hansen L, Salmon D, Galasko D, Masliah E, Katzman R, DeTeresa R, Thal L, Pay MM, Hofstetter R, Klauber M. PMID: 2153271.
      View in: PubMed   Mentions: 139     Fields:    Translation:HumansCells
    356. The Mini-Mental State Examination in the early diagnosis of Alzheimer's disease. Arch Neurol. 1990 Jan; 47(1):49-52. Galasko D, Klauber MR, Hofstetter CR, Salmon DP, Lasker B, Thal LJ. PMID: 2294894.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    357. Lobar atrophy with dense-core (brain stem type) Lewy bodies in a patient with dementia. Acta Neuropathol. 1990; 80(4):453-8. Masliah E, Galasko D, Wiley CA, Hansen LA. PMID: 2173332.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    358. Intracranial mass lesions associated with late-onset psychosis and depression. Psychiatr Clin North Am. 1988 Mar; 11(1):151-66. Galasko D, Kwo-On-Yuen PF, Thal L. PMID: 3288979.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    359. Ataxic hemiparesis with intact sensory modalities. Arch Neurol. 1986 Jan; 43(1):8. Schleimer J, Galasko D, Stern BJ. PMID: 3942522.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    Douglas's Networks
    Concepts (782)
    Derived automatically from this person's publications.
    _
    Co-Authors (129)
    People in Profiles who have published with this person.
    _
    Similar People (57)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _